Introduction {#s1}
============

Transcription initiation is a major control point for gene expression. In bacteria, a single RNA polymerase (RNAP) performs all transcription. In *Escherichia coli* (*Eco*), the essential primary σ factor, σ^70^, binds to RNAP to form the σ^70^-holoenzyme (Eσ^70^) that is capable of recognizing and initiating at promoters for most genes. Upon locating the promoter, Eσ^70^ melts a \~ 13 bp segment of DNA to form the open promoter complex (RPo) in which the DNA template strand (t-strand) is loaded into the RNAP active site, exposing the transcription start site ([@bib5]; [@bib88]). A key feature of the RPo formation pathway is that it is a multi-step process, with the RNAP-promoter complex passing through multiple intermediates before the final, transcription competent RPo is formed ([@bib33]; [@bib68]; [@bib72]).

A variety of transcription factors bind to the promoter DNA and/or to RNAP directly to regulate initiation ([@bib14]; [@bib31]). Bacterial RNAP-binding factors, encoded by the chromosome or by bacteriophage or extrachromosomal elements, interact with different regions of the enzyme to regulate its functions ([@bib31]). One such factor is ppGpp, a modified nucleotide that functions together with the RNAP-binding protein DksA in *Eco* to reprogram bacterial metabolism in response to nutritional stresses during the so-called stringent response. Following amino acid starvation, ppGpp is synthesized by the RelA factor in response to uncharged tRNAs in the ribosomal A site ([@bib13]; [@bib17]; [@bib71]). Together, ppGpp and DksA alter the expression of as many as 750 genes within 5 min of ppGpp induction ([@bib54]; [@bib56]; [@bib73]), inhibiting, for example, promoters responsible for ribosome biogenesis and activating promoters responsible for amino acid synthesis.

The overall RNAP structure is reminiscent of a crab claw, with one pincer comprising primarily the β' subunit, and the other primarily the β subunit ([@bib84]). Between the two pincers is a large cleft that contains the active site. In Eσ^70^ without nucleic acids, this channel is occupied by the σ^70^~1.1~ domain which is ejected upon entry of the downstream duplex DNA ([@bib3]; [@bib47]). The Bridge Helix (BH) bridges the two pincers across the cleft, separating the cleft into the main channel, where σ^70^~1.1~ or nucleic acids reside, and the secondary channel, where NTPs enter the RNAP active site.

DksA binds in the RNAP secondary channel ([@bib41]; [@bib49]; [@bib57]). ppGpp binds directly to RNAP at two binding sites: site 1, located at the interface of the β′ and ω subunits ([@bib66]; [@bib87]), and site 2, located at the interface of β′ and DksA ([@bib49]; [@bib67]). The ppGpp bound at site one inhibits transcription \~2 fold under conditions where the effects of ppGpp bound at both sites together with DksA are as much as 20-fold ([@bib55]; [@bib67]). By contrast, ppGpp/DksA at site two has a larger effect on inhibition and is necessary and sufficient for activation ([@bib67]).

TraR is a distant homolog of DksA. Although only half the length of DksA, TraR regulates *Eco* transcription by binding to the RNAP secondary channel and mimicking the combined effects of ppGpp and DksA ([@bib28]). TraR is encoded by the conjugative F plasmid and is expressed from the pY promoter as part of the major *tra* operon transcript ([@bib26]; [@bib44]). Like DksA, TraR inhibits Eσ^70^-dependent transcription from ribosomal RNA promoters (e.g. *rrnB* P1) and ribosomal protein promoters (e.g. *rpsT* P2, expressing S20), and activates amino acid biosynthesis and transport promoters (e.g. p*thrABC,* p*hisG,* p*argI,* p*livJ*) in vivo and in vitro ([@bib28]). The affinity of TraR for RNAP is only slightly higher than that of DksA, yet its effects on promoters negatively regulated by ppGpp/DksA in vitro are as large or larger than those of ppGpp/DksA ([@bib28]). The effects of TraR on promoters positively regulated by ppGpp/DksA are also independent of ppGpp ([@bib28]).

Models for ppGpp/DksA and TraR binding to RNAP have been proposed based on biochemical and genetic approaches ([@bib28]; [@bib53]; [@bib66]; [@bib67]). Crystal structures of ppGpp/DksA/RNAP and TraR/RNAP confirmed the general features of these models and provided additional detail about their interactions with RNAP ([@bib49]), but did not reveal the mechanism of inhibition or activation, in large part because of crystal packing constraints on the movement of mobile regions of the complex. Thus, the structural basis for the effects of ppGpp/DksA or TraR on transcription has remained elusive.

To help understand TraR regulation and principles of the regulation of transcription initiation in general, we used single particle cryo-electron microscopy (cryo-EM) to examine structures of Eσ^70^ alone, Eσ^70^ bound to TraR (TraR-Eσ^70^), and Eσ^70^ bound to a promoter inhibited by TraR \[*rpsT* P2; [@bib28]\]. Cryo-EM allows the visualization of multiple discrete conformational states populated in solution and in the absence of crystal packing constraints. Furthermore, new software tools allow for the analysis of continuous distributions of conformational heterogeneity in the cryo-EM data ([@bib52]).

The TraR-Eσ^70^ structures show TraR binding in the secondary channel of the RNAP, consistent with the TraR-Eσ^70^ model ([@bib28]) and crystal structure ([@bib49]). However, the cryo-EM structures reveal major TraR-induced changes to the RNAP conformation that were not evident in the crystal structure due to crystal packing constraints. Structural analyses generated mechanistic hypotheses for TraR function in both activation and inhibition of transcription that were then tested biochemically. Based on the combined structural and functional analyses, we propose a model in which TraR accelerates multiple steps along the RPo formation pathway and at the same time modulates the relative stability of intermediates in the pathway. Whether a promoter is activated or inhibited by TraR is determined by the intrinsic kinetic properties of the promoter ([@bib27]; [@bib31]; [@bib56]).

Results {#s2}
=======

Cryo-EM structures of TraR-Eσ^70^, Eσ^70^, and *rpsT* P2 RPo {#s2-1}
------------------------------------------------------------

We used single-particle cryo-EM to examine the structure of the *Eco* TraR-Eσ^70^ complex in the absence of crystal packing interactions that could restrict conformational states of the complex. We also determined cryo-EM structures of Eσ^70^ alone and the Eσ^70^-*rpsT* P2 promoter RPo for comparison. TraR function under cryo-EM solution conditions ([@bib20]) was indistinguishable from function under standard in vitro transcription assay conditions ([Figure 1---figure supplement 1A--C](#fig1s1){ref-type="fig"}).

Analysis of the cryo-EM data for the TraR-Eσ^70^ complex gave rise to three distinct conformational classes ([Figure 1---figure supplement 1D](#fig1s1){ref-type="fig"}). All three structures are essentially identical except for the disposition of Si3 \[also called β'i6; [@bib38]\], a 188-residue lineage-specific insertion (LSI) in the trigger-loop (TL) of *Eco* RNAP ([@bib21]) ([Figure 1A,B](#fig1){ref-type="fig"}). The first class \[TraR-Eσ^70^(I)\] contained approximately 41% of the particles and resolved to a nominal resolution of 3.7 Å ([Figure 1A](#fig1){ref-type="fig"}). The second class \[TraR-Eσ^70^(II)\] contained approximately 33% of the particles and resolved to a nominal resolution of 3.8 Å ([Figure 1B](#fig1){ref-type="fig"}). The third class \[TraR-Eσ^70^(III)\] contained the remaining 26% of the particles and resolved to a nominal resolution of 3.9 Å ([Figure 1---figure supplement 1D](#fig1s1){ref-type="fig"}, [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}; [Supplementary file 1](#supp1){ref-type="supplementary-material"}). With Si3 (β' residues 948--1126) excluded, the structures superimpose with a root-mean-square deviation (rmsd) of 0.495 Å over 3,654 α-carbons.

![Cryo-EM structure of TraR-Eσ^70^.\
(*top*) Color-coding key. (**A**) TraR-Eσ^70^(I) - cryo-EM density map (3.7 Å nominal resolution, low-pass filtered to the local resolution) is shown as a transparent surface and colored according to the key. The final model is superimposed. (**B**) TraR-Eσ^70^(II) - cryo-EM density map (3.8 Å nominal resolution, low-pass filtered to the local resolution) is shown as a transparent surface and colored according to the key. The final model is superimposed. (**C**) Top view of TraR-Eσ^70^(I). The boxed area is magnified in (**D**). (**D**) Magnified top view of TraR-Eσ^70^(I) - shows TraR~N~ (starting near RNAP active site Mg^2+^, extending out secondary channel), TraR~G~ (interacting primarily with β\'rim-helices), and TraR~C~ (interacting with βlobe-Si1). (**E -- G**) Cryo-EM density (blue mesh) defining the TraR structure. (**E**) TraR~N~ and -NADFDGD- motif of RNAP β\' (chelating active site Mg^2+^). (**F**) TraR~G~. (**G**) TraR ~C~.](elife-49375-fig1){#fig1}

The overall binding mode of TraR in the cryo-EM structures ([Figure 1A--D](#fig1){ref-type="fig"}) is consistent with the effects of TraR or RNAP substitutions on TraR function ([@bib28]) and is broadly consistent with the X-ray structure ([@bib49]). TraR can be divided into three structural elements, an N-terminal helix (TraR~N~, residues 2--27; [Figure 1D,E](#fig1){ref-type="fig"}), a globular domain (TraR~G~, residues 28--57; [Figure 1D,F](#fig1){ref-type="fig"}), and a C-terminal helix (TraR~C~, residues 58--73; [Figure 1D,G](#fig1){ref-type="fig"}). A 4-Cys Zn^2+^-binding motif spans TraR~G~ and TraR~C~ ([Figure 1F](#fig1){ref-type="fig"}). TraR~N~ extends from the RNAP active site out through the RNAP secondary channel to the β'rim-helices (at the entrance to the RNAP secondary channel), interacting with key RNAP structural elements surrounding the active site, including the -NADFDGD- motif that chelates the active site Mg^2+^ ([@bib84]), the F-loop ([@bib48]), and the bridge-helix ([Figure 1D](#fig1){ref-type="fig"}). The N-terminal tip of TraR~N~ (TraR residue S2) is only 4.3 Å from the active site Mg^2+^ ([Figure 1E](#fig1){ref-type="fig"}). TraR~G~ interacts primarily with the β'rim-helices at the entrance of the secondary channel ([Figure 1D](#fig1){ref-type="fig"}).

The interactions of TraR~C~ with RNAP differ substantially between the cryo-EM and X-ray structures due to conformational changes induced by TraR binding detected by the cryo-EM structure that were not observed in the X-ray structure (see below). Indeed, the cryo-EM and X-ray structures superimpose with an rmsd of 4.26 Å over 3,471 α-carbons, indicating significant conformational differences.

Cryo-EM data for Eσ^70^ resolved to a nominal resolution of 4.1 Å ([Figure 1---figure supplements 3](#fig1s3){ref-type="fig"} and [4](#fig1s4){ref-type="fig"}; [Supplementary file 1](#supp1){ref-type="supplementary-material"}). Analysis of the *rpsT* P2-RPo cryo-EM data ([Figure 2](#fig2){ref-type="fig"}) gave rise to two conformational classes that differed only in the disposition of the upstream promoter DNA and αCTDs ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). We focus here on the highest resolution class at a nominal resolution of 3.4 Å ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}, [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}; [Supplementary file 1](#supp1){ref-type="supplementary-material"}).

![Cryo-EM structure of *rpsT* P2-RPo.\
(**A**) The *Eco rpsT* P2 promoter fragment used for cryo-EM. (**B**) *rpsT* P2-RPo cryo-EM density map (3.4 Å nominal resolution, low-pass filtered to the local resolution) is shown as a transparent surface and colored according to the key. The final model is superimposed. The DNA was modeled from −45 to +21. The t-strand DNA from −10 to −2, and the nt-strand DNA from −3 to +2 were disordered. (**C**) Top view of *rpsT* P2-RPo. DNA is shown as atomic spheres. Proteins are shown as molecular surfaces. Much of the β subunit is transparent to reveal the active site Mg^2+^ (yellow sphere), σ^70^~finger~, and DNA inside the RNAP active site cleft.](elife-49375-fig2){#fig2}

The closed-clamp RNAP in the *rpsT* P2-RPo cryo-EM structure interacts with the promoter DNA in the same way as in RPo structures determined by X-ray crystallography ([@bib5]; [@bib4]; [@bib34]) or cryo-EM ([@bib12]) and is consistent with the DNase I footprint of the *rpsT* P2 RPo ([@bib28]). In the *rpsT* P2-RPo structure we observed an α-subunit C-terminal domain \[αCTD; [@bib63]\] bound to the promoter DNA minor groove ([@bib10]; [@bib64]) just upstream of the promoter −35 element \[−38 to −43, corresponding to the proximal UP element subsite; [@bib24]\]. This αCTD interacts with σ^70^~4~ through an interface previously characterized through genetic analyses ([@bib65]) ([Figure 2B,C](#fig2){ref-type="fig"}). The αCTDs are linked to the α-N-terminal domains (αNTDs) by \~15 residue flexible linkers ([@bib11]; [@bib36]). Density for the residues connecting the αCTD and αNTD was not observed in the cryo-EM map.

Comparing the RNAP conformations of the TraR-Eσ^70^, Eσ^70^, and *rpsT* P2-RPo cryo-EM structures revealed key differences that suggest how TraR activates and inhibits transcription. Below we outline these differences and test their implications for function.

β'Si3 is in two conformations, one of which is important for TraR activation function {#s2-2}
-------------------------------------------------------------------------------------

The three TraR-Eσ^70^ structures differ from each other only in the disposition of Si3. Si3 comprises two tandem repeats of the sandwich-barrel hybrid motif (SBHM) fold ([@bib21]; [@bib35]), SBHMa and SBHMb ([Figure 3A](#fig3){ref-type="fig"}). Si3 is linked to the TL-helices by extended, flexible linkers. In TraR-Eσ^70^(I) and TraR-Eσ^70^(II), Si3 is in two distinct positions with respect to the RNAP ([Figures 1A, B](#fig1){ref-type="fig"} and [3A](#fig3){ref-type="fig"}), while in TraR-Eσ^70^(III) Si3 is disordered ([Figure 1---figure supplement 1D](#fig1s1){ref-type="fig"}). Si3 in the TraR-Eσ^70^(I) structure \[Si3(I)\] interacts primarily with the β'shelf (SBHMa) and the β'jaw (SBHMb) in a manner seen in many previous *Eco* RNAP X-ray ([@bib3]) and cryo-EM structures ([@bib19]; [@bib37]; [@bib42]). Si3 in the TraR-Eσ^70^(II) structure \[Si3(II)\] is rotated 121° such that SBHMa interacts with the β'jaw and SBHMb interacts with TraR~G~ ([Figure 3A--C](#fig3){ref-type="fig"}), a disposition of Si3 that, to our knowledge, has not been observed previously.

![Conformational flexibility of β\'Si3 in TraR-Eσ^70^.\
(**A**) Overall view of TraR-Eσ^70^ structure with alternative positions of Si3. Si3(I) is shown in brown. A \~ 121° rotation about the rotation axis shown gives rise to the position of Si3(II) shown in magenta. Si3 comprises two SBHM domains ([@bib21]; [@bib35]), denoted SBHMa and SBHMb. The boxed region is magnified in (**B**). (**B**) Magnified view of TraR-Eσ^70^(II) \[same view as (A)\]. The position of Si3(II) is outlined in magenta but the rest of Si3 is removed, revealing TraR behind. Three residues central to the TraR-Si3(II) interface (TraR-E46, R49, and K50) are colored yellow. (**C**) Orthogonal view as (**B**), showing the extensive TraR-Si3(II) interface. (**D**) -- (**G**) Si3 interaction with TraR~G~ affects activation but not inhibition. Quantifications show averages with range from two independent experiments. (**D**) (top) Multi round in vitro transcription of *rrnB* P1 over a range of TraR concentrations (wedge indicates 2 nM - 2 µM) in the presence of WT-RNAP or ∆Si3-RNAP as indicated. Plasmid templates also contained the RNA-1 promoter. (bottom) Quantification of transcripts from experiments like those shown on (top) plotted relative to values in the absence of TraR. The IC~50~ for inhibition by TraR was \~40 nM for both data sets. (**E**) (top) Multi round in vitro transcription of *thrABC* over a range of TraR concentrations (wedge indicates 2 nM - 2 µM) in the presence of 20 nM WT-RNAP or ∆Si3-RNAP as indicated. Plasmid templates also contained the RNA-1 promoter. (bottom) Quantification of transcripts from experiments like those shown on (top) plotted relative to values in the absence of TraR. (**F**) and (**G**) Multi round in vitro transcription of *rrnB* P1 (**F**) or p*thrABC* (**G**) was performed with 20 nM WT-Eσ^70^ at a range of concentrations of WT or variant TraR (2 nM −2 µM). Transcripts were quantified and plotted relative to values in the absence of any factor (n = 2). For (**F**) IC~50~ for inhibition by WT-TraR was \~50 nM, by E46A TraR was \~115 nM, R49A TraR was \~85 nM and by K50A TraR was \~30 nM.](elife-49375-fig3){#fig3}

To test if this alternative conformation \[Si3(II)\] is relevant to TraR function, we compared TraR-mediated function with wild-type (WT) and ΔSi3-RNAPs at promoters where TraR inhibits or activates transcription. Deletion of Si3 had little to no effect on TraR-mediated inhibition of *rrnB* P1 and *rpsT* P2 ([Figure 3D](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}) but transcription by ΔSi3-RNAP was activated only \~50% compared with WT-RNAP on three different TraR-activated promoters (p*thrABC*, [Figure 3E](#fig3){ref-type="fig"}; p*argI*, [Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}; p*hisG*, [Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"}).

Three TraR~G~ residues (TraR-E46, R49, and K50) are central to the Si3-TraR~G~ interface ([Figure 3B,C](#fig3){ref-type="fig"}). Individual alanine substitutions of these TraR residues (TraR-E46A, R49A, or K50A) gave rise to similar results as deleting Si3. Inhibition of *rrnB* P1 was similar to WT-TraR for TraR-K50A, and mildly impaired for TraR-E46A or R49A ([Figure 3F](#fig3){ref-type="fig"}; legend for IC~50~ values). Maximal inhibition was achieved at higher E46A or R49A TraR concentrations. However, these same variants exhibited at least \~2 fold reduced activation at the *thrABC* promoter ([Figure 3G](#fig3){ref-type="fig"}) even at saturating TraR concentrations, indicating a role for the TraR-Si3 interaction in the mechanism of activation. Consistent with these results, these TraR variants were proficient in RNAP binding in a competition assay ([Figure 3---figure supplement 1F](#fig3s1){ref-type="fig"}). By contrast, substitutions for nearby TraR variants P43A and P45A were defective for binding to RNAP, and their functional defects were overcome at higher TraR concentrations ([Figure 3---figure supplement 1D--F](#fig3s1){ref-type="fig"}).

The combination of the TraR-Si3 interface and the ΔSi3-RNAP mutants was epistatic; the same \~2 fold reduction in activation was observed as with the Si3-TraR interface mutants or the ΔSi3-RNAP mutant individually ([Figure 3---figure supplement 1G](#fig3s1){ref-type="fig"}). These results indicate that the Si3(SBHMb)-TraR~G~ interaction enabled by the Si3(II) conformation accounts for part of the TraR-mediated effect on activation.

A TraR-induced \~18° rotation of βlobe-Si1 plays a major role in transcription regulation {#s2-3}
-----------------------------------------------------------------------------------------

The large cleft between the two pincers in the structure of RNAP forms a channel that accommodates the downstream duplex DNA between the β'shelf and the clamp on one side, and the βlobe-Si1 domains on the other ([Figure 2B,C](#fig2){ref-type="fig"}). In Eσ^70^ without nucleic acids, this channel is occupied by the σ^70^~1.1~ domain, which is ejected upon entry of the downstream duplex DNA ([Figure 1D](#fig1){ref-type="fig"}) ([@bib3]; [@bib47]). TraR binding induces a \~ 18° rotation of the RNAP βlobe-Si1 domains (the two domains move together as a rigid body), shifting the βlobe-Si1 towards TraR, allowing the βlobe-Si1 to establish an interface with TraR~G~ and TraR~C~ (615 Å^2^ interface area; [Figure 4A](#fig4){ref-type="fig"}).

![TraR and the βlobe-Si1 domain.\
(**A**) Overall top view of the TraR-Eσ^70^ structure with the βlobe-Si1 in dark blue. The corresponding position of the βlobe-Si1 in the *rpsT* P2-RPo structure ([Figure 2](#fig2){ref-type="fig"}) is shown in light blue. The βlobe-Si1 of the *rpsT* P2-RPo structure (light blue) undergoes an \~18° rotation about the rotation axis shown to the βlobe-Si1 position in the TraR-Eσ^70^ structure (dark blue), generating an extensive TraR-βlobe-Si1 interface. (**B**) Transcription of inhibited promoter *rpsT* P2 by 20 nM WT-RNAP or ΔSi1-RNAP with (+) or without (-) 250 nM TraR as indicated. Error bars denote standard deviation of three independent measurements. (**C**) Transcription of activated promoter p*argI* by 20 nM WT-RNAP or ΔSi1-RNAP with (+) or without (-) 250 nM TraR as indicated. Error bars denote standard deviation of three independent measurements. (**D**) (top) Multi-round in vitro transcription was carried out at a range of TraR concentrations (wedge indicates 4 nM - 4 μM) in the presence of 20 nM WT-Eσ^70^ or EΔ1.1σ^70^ as indicated. Plasmid template also contained the RNA-1 promoter. (bottom) Transcripts from experiments such as those in (top) were quantified and plotted relative to values in the absence of TraR with WT-Eσ^70^ or EΔ1.1σ^70^ with (+) or without (-) 250 nM TraR as indicated. Averages with range from two independent experiments are shown.](elife-49375-fig4){#fig4}

Si1 \[also called βi4; [@bib38]\] is an LSI within the βlobe. Most of the TraR/βlobe-Si1 interface (77%) is between TraR and Si1. Deleting Si1 from RNAP nearly abolishes activation function \[p*argI,* [Figure 4C](#fig4){ref-type="fig"}; *thrABC*, [@bib28]\], even at saturating concentrations of TraR to overcome weakened TraR binding ([@bib28]). These results suggest that the βlobe-Si1 rotation induced by TraR is essential to TraR-mediated activation.

The rotation of the βlobe-Si1 widens the gap between the βprotrusion and the βlobe ([Figure 4A](#fig4){ref-type="fig"}) and changes the shape of the RNAP channel, altering RNAP contacts with σ^70^~1.1~ in Eσ^70^. We hypothesize that altering the RNAP contacts with σ^70^~1.1~ in the channel facilitates σ^70^~1.1~ ejection during RPo formation, contributing to activation of promoters that are limited at this step. To test this hypothesis, we investigated TraR function on an inhibited (*rrnB* P1) and an activated (*thrABC*) promoter with holoenzyme lacking σ^70^~1.1~ (EΔ1.1σ^70^).

Eσ^70^ exhibited weak transcription from the *thrABC* promoter in the absence of TraR (referred to here as basal transcription), and transcription from this promoter was stimulated about \~4 fold in the presence of TraR ([Figure 4D](#fig4){ref-type="fig"}). EΔ1.1σ^70^ exhibited a striking increase in basal transcription activity from this promoter (\~32 fold) compared to WT-Eσ^70^ activity ([Figure 4D](#fig4){ref-type="fig"}). Only a small further increase in transcription was observed upon the addition of TraR ([Figure 4D](#fig4){ref-type="fig"}). These results suggest that σ^70^~1.1~ is an obstacle to promoter DNA entering the RNAP channel and that TraR partially overcomes this barrier. In contrast to deletion of region σ^70^~1.1~, which almost entirely bypassed the requirement for TraR, rotation of the βlobe-Si1 did not weaken σ^70^~1.1~-RNAP contacts sufficiently to release σ^70^~1.1~ completely ([Figure 1D](#fig1){ref-type="fig"}). Rather, we propose that βlobe-Si1 rotation facilitated the competition between promoter DNA and σ^70^~1.1~ during RPo formation. Our results suggest that TraR-activated promoters are defined, in part, by being limited at the σ^70^~1.1~ ejection step, but that the system has evolved to allow activation of WT-RNAP to a level appropriate for the biological need for the gene products, not the maximum level that could be achieved by full ejection of σ^70^~1.1~.

βSi1 was also required for inhibition of *rpsT* P2 ([Figure 4B](#fig4){ref-type="fig"}) and *rrnB* P1 transcription by TraR ([@bib28]). However, in contrast to the effect of EΔ1.1σ^70^ on activated promoters, deletion of σ^70^~1.1~ had little effect on basal transcription from the TraR-inhibited *rrnB* P1 promoter; inhibition of *rrnB* P1 by TraR with EΔ1.1σ^70^ was only slightly defective ([Figure 4---figure supplement 1A,B](#fig4s1){ref-type="fig"}). Thus, in contrast to the effects of Si1 on activation by TraR, we suggest that the effect of TraR on inhibition of transcription involves the βlobe-Si1 domains but this is not mediated by σ^70^~1.1~ (see Discussion). We propose that TraR-mediated stimulation of σ^70^~1.1~ release still occurs at inhibited promoters like *rrnB* P1 and *rpsT* P2, but this has little effect on transcription because these promoters are limited by their unstable RPo ([@bib8]) ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}).

In summary, deletion of σ^70^~1.1~ has a major effect on basal transcription of an activated promoter ([Figure 4D](#fig4){ref-type="fig"}) but only a minor effect on an inhibited promoter ([Figure 4---figure supplement 1A,B](#fig4s1){ref-type="fig"}). To qualitatively understand this striking result in terms of kinetic/energetic schemes for transcription initiation from a hypothetical inhibited and activated promoter, we adapted the flux calculator ([@bib27]) to a four-step linear mechanism (see Materials and methods) that culminates in the irreversible generation of RP~ITC~ that has initiated RNA chain synthesis ([@bib15]; [@bib61]; [@bib75]; [@bib70]; [@bib69]; [@bib33]):$$R + P\rightleftarrows RP1\rightleftarrows RP2\rightleftarrows RPo\rightarrow RP_{ITC}$$

Ejection of σ^70^~1.1~ is thought to be a relatively late step on the pathway to RPo formation ([@bib68]) so we modeled the effect of deleting σ^70^~1.1~ as lowering the kinetic barrier separating RP2 and RPo ([Figure 4---figure supplement 1C](#fig4s1){ref-type="fig"}). The basal energy landscapes for a hypothetical inhibited and activated promoter were modeled after ([@bib27]) \[see Figure 6B of [@bib27]. The overall qualitative kinetic/thermodynamic features of inhibited vs. activated promoters are described later in the Discussion. The details of how we used the flux calculator ([@bib27]) are described in Materials and methods and [Supplementary file 2](#supp2){ref-type="supplementary-material"}. In this scheme, lowering the kinetic barrier separating RP2 and RPo has no effect on transcription output from the negatively regulated promoter but gives rise to a large increase in transcription output from the positively regulated promoter ([Figure 4---figure supplement 1C](#fig4s1){ref-type="fig"}), reflecting the experimental results ([Figure 4D](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1A,B](#fig4s1){ref-type="fig"}).

TraR induces β'shelf rotation and a bridge-helix kink, contributing to inhibition {#s2-4}
---------------------------------------------------------------------------------

TraR binding induces a \~ 4.5° rotation of the β'shelf module ([Figure 5A,B](#fig5){ref-type="fig"}). The BH leads directly into the shelf module, and a kink is introduced in the BH, a long α-helix that traverses the RNAP active site cleft from one pincer to the other, directly across from the active site Mg^2+^ ([Figure 5B,C](#fig5){ref-type="fig"}). The BH plays critical roles in the RNAP nucleotide addition cycle ([@bib39]), including interacting with the t-strand DNA at the active site ([Figure 5D](#fig5){ref-type="fig"}). TraR causes the BH to kink towards the t-strand DNA ([Figure 5C](#fig5){ref-type="fig"}), similar to BH kinks observed previously ([@bib79]; [@bib78]; [@bib81]; [@bib84]), resulting in a steric clash with the normal position of the t-strand nucleotide at +2 ([Figure 5E](#fig5){ref-type="fig"}). Thus, the TraR-induced BH kink would sterically prevent the proper positioning of the t-strand DNA in RPo, likely contributing to inhibition of transcription.

![TraR rotates the β\'shelf and kinks the BH.\
(**A**) Overall view if the TraR-Eσ^70^(I) structure, shown as a molecular surface. The β\'shelf domain is highlighted in hot pink. The β\'shelf (which here includes the β\'jaw) comprises *Eco* β\' residues 787-931/1135-1150/1216-1317. The boxed region is magnified in (**B**). (**B**) Comparison of the *rpsT* P2-RPo BH-β\'shelf (pink) and the TraR-Eσ^70^ BH-β\'shelf (hot pink). Binding of TraR induces an \~4.5° rotation (about the rotation axis shown) of the RPo-β\'shelf to the position of the TraR-Eσ^70^ β\'shelf and a kink in the BH (circled region, which is magnified in (**C**)). (**C**) Focus on the region of the BH kink, which is centered near β\'L788. The kink in the RPo BH is about 25°, while the kink in the TraR-Eσ^70^ BH is about 29°. (**D**) View down the axis of the *rpsT* P2-RPo BH. The t-strand DNA, positioned at the RNAP active site (marked by the Mg^2+^ ion), closely approaches the BH. (**E**) View down the axis of the TraR-Eσ^70^ BH. The BH kink induced by TraR binding sterically clashes with the position of the t-strand DNA (superimposed from the RPo structure).](elife-49375-fig5){#fig5}

TraR binding restricts the range of clamp positions in Eσ^70^ {#s2-5}
-------------------------------------------------------------

TraR induces conformational changes in the RNAP β\'Si3 ([Figure 1A,B](#fig1){ref-type="fig"}), βlobe-Si1 ([Figure 4A](#fig4){ref-type="fig"}), β\'shelf, and BH ([Figure 5](#fig5){ref-type="fig"}) structural modules. We noted modest changes in clamp positions ([Supplementary file 3](#supp3){ref-type="supplementary-material"}), but we suspected that conformational heterogeneity of Eσ^70^ (limiting the resolution of the single particle analysis; [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}) likely arose primarily from a continuous distribution of clamp positions that could not be easily classified into distinct conformational states. We also suspected that the range of clamp positions was dampened in the TraR-Eσ^70^ and *rpsT* P2-RPo structures. We therefore analysed and compared the heterogeneity of RNAP clamp positions between the Eσ^70^, TraR-Eσ^70^, and *rpsT* P2-RPo datasets using multibody refinement as implemented in RELION 3 ([@bib52]). The maps used for multi-body refinement were carefully chosen to be equivalently processed. After initial classification to remove junk particles, particles were 3D auto-refined, then the refinement metadata and post-processing were used as inputs for RELION CTF refinement and Bayesian Polishing ([@bib86]). After a final round of 3D auto-refinement (but no further classification), the *rpsT* P2-RPo dataset had the smallest number of particles (370,965), so a random subset of particles from the other datasets (TraR-Eσ^70^ and Eσ^70^) were processed so that each map for multi-body refinement was generated from the same number of particles (370,965). The final maps used for multi-body refinement had nominal resolutions of 4.0 Å (TraR-Eσ^70^; red dashed box in [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), 4.6 Å (Eσ^70^; red dashed box in [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}), and 3.5 Å (*rpsT* P2-RPo; red dashed box in [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). We note that dynamic clamp behavior has been observed by single-molecule FRET in solution ([@bib22]).

For Eσ^70^, three major components (Eigenvectors) of clamp changes were revealed ([Figure 6A--D](#fig6){ref-type="fig"}). For each Eigenvector, the histogram of Eigenvalues closely approximated a Gaussian distribution ([Figure 6B--D](#fig6){ref-type="fig"}). To quantitate the range of clamp conformations represented by the Eigenvalues, we divided the particles into three bins according to their Eigenvalues such that each bin contained an equal number of particles (red, gray, and blue in [Figure 6B--D](#fig6){ref-type="fig"}). Three-dimensional alignments and reconstructions were then calculated for each bin.

![Multi-body analysis of Eσ^70^ clamp conformational changes.\
(**A**) Model of Eσ^70^ refined into the consensus cryo-EM map (nominal 4.1 Å resolution). The RNAP clamp is highlighted in magenta. The clamp (which in the context of Eσ^70^ includes σ^70^~2~) comprises the following *Eco* RNAP residues: β 1319--1342; β\' 1--342, 1318--1344; σ^70^92--137, 353--449. The mask used to analyze clamp motions by multi-body refinement ([@bib52]) is shown as a transparent yellow surface. (**B - D**) Histograms of Eigenvalue distributions (% of particles assigned each Eigenvalue from the dataset) for each of the three major principle components (Eigenvectors) from the multi-body analysis ([@bib52]). Each set of particles were divided into three equal-sized bins (red; gray; blue). The solid lines denote Gaussian fits to the histograms. (**B**) Component 1. (**C**) Component 2. (**D**) Component 3. (**E - G**) Three-dimensional reconstructions were calculated from the red and blue-binned particles for each principal component and models were generated by rigid body refinement. The models were superimposed using α-carbons of the RNAP structural core, revealing the alternate clamp positions shown (red and blue α-carbon ribbons with cylindrical helices). The σ^70^~NCR~, attached to the clamp but not included in the clamp motion analyses, is shown in faded colors. For each component, the clamp rotation and the direction of the rotation axis were determined (rotation axes are shown in gray). (**E**) Component 1 - clamp opening/closing. (**F**) Component 2 - clamp twisting. (**G**) Component 3 - clamp rolling.](elife-49375-fig6){#fig6}

For component 1, the red and blue particles gave rise to reconstructions that differed in clamp positions by a rotation angle of 2.7° in a direction we call opening/closing ([Figure 6E](#fig6){ref-type="fig"}). The low Eigenvalue particles yielded a closed clamp (red), while the high Eigenvalue particles (blue) gave an open clamp. In the middle, the particles having intermediate Eigenvalues (gray) gave a clamp position half-way in between the red and the blue, as expected (not shown).

Component two gave rise to clamp positions that differed by a 4.6° rotation about a rotation axis roughly perpendicular to the open/close rotation axis, a conformational change we call twisting ([Figure 6F](#fig6){ref-type="fig"}). Finally, component three gave rise to clamp positions that differed by a 2.0° rotation about a third rotation axis parallel with the long axis of the clamp, a conformational change we call rolling ([Figure 6G](#fig6){ref-type="fig"}).

Using the parameters of the Gaussian fits to the Eigenvalue histograms ([Figure 6B--D](#fig6){ref-type="fig"}), we could estimate the full range of clamp rotations for each component, which we defined as the rotation range that accounted for 98% of the particles (excluding 1% of the particles at each tail; [Figure 7](#fig7){ref-type="fig"}).

![Range of clamp conformations for *Eco* RNAP complexes.\
(top) Eσ^70^ is shown as a molecular surface (α, ω, light gray; β, light cyan; β\', light pink; σ^70^, light orange) except the clamp/σ^70^~2~ module is shown schematically as blue or red outlines (the σ^70^~NCR~ is omitted for clarity) to illustrate the direction and approximate range for the three major components of the clamp conformational changes (left, opening/closing; middle, twisting; left, rolling). (bottom) Histograms denote the range of clamp conformational changes for Eσ^70^, TraR-Eσ^70^, and *rpsT* P2-RPo, as indicated. The black bars denote the rotation range defined by dividing the Eigenvalue histograms into three equal bins and determining the clamp position for the red and blue bins (−33 %/+33% bin; see [Figure 6](#fig6){ref-type="fig"}). The gray bars denote the estimated rotation range to include 98% of the particles calculated from the Gaussian fits to the Eigenvalue histograms (1% of the particles excluded from each tail; see [Figure 6](#fig6){ref-type="fig"}).](elife-49375-fig7){#fig7}

These same conformational changes (opening/closing, twisting, rolling) were represented in major components of clamp changes for the TraR-Eσ^70^ and *rpsT* P2-RPo particles as well. The same analyses revealed that TraR binding significantly reduced the range of clamp positions for each of the three clamp motions ([Figure 7](#fig7){ref-type="fig"}). As expected, the clamp positions for RPo, with nucleic acids stably bound in the downstream duplex channel, were restricted even further for all three of the major clamp motions ([Figure 7](#fig7){ref-type="fig"}). See Discussion for potential mechanism(s) of effects of clamp conformational changes on transcription.

Discussion {#s3}
==========

Our cryo-EM structural analyses show that TraR modulates *Eco* RNAP transcription initiation by binding to and altering the discrete conformation, as well as the conformational heterogeneity, of the RNAP in four major ways: (1) manipulation of the disposition of β\'Si3 ([Figures 1A, B](#fig1){ref-type="fig"} and [3](#fig3){ref-type="fig"}); (2) alteration of the shape of the RNAP active site cleft through a large rearrangement of the βlobe-Si1 ([Figure 4](#fig4){ref-type="fig"}); (3) induction of a significant kink in the BH ([Figure 5](#fig5){ref-type="fig"}); and (4) dampening the range of clamp positions ([Figures 6](#fig6){ref-type="fig"} and [7](#fig7){ref-type="fig"}; [Video 1](#video1){ref-type="video"}). A previous crystal structure analysis showed that TraR could diffuse into crystals of *Eco* Eσ^70^ and interact with the RNAP β\'rim-helices and secondary channel ([@bib49]), but none of these four major TraR-mediated conformational changes seen in the cryo-EM analysis presented here were observed in the crystal structure ([Supplementary file 3](#supp3){ref-type="supplementary-material"}). Comparing RNAP conformations, the TraR-Eσ^70^ crystal structure (5W1S) matches the Eσ^70^ crystal structure \[4YG2, the same crystal form from which the TraR complex was derived; [@bib50]\] much more closely than the TraR-Eσ^70^ cryo-EM structure ([Supplementary file 3](#supp3){ref-type="supplementary-material"}). Thus, crystal packing constraints prevented the conformation of the RNAP from properly responding to TraR binding.

###### Video illustrating changes in conformation and conformational dynamics of RNAP induced by TraR binding.

Our results highlight important advantages of cryo-EM over crystallography for structural analysis of large, conformationally dynamic molecular machines such as RNAP ([@bib6]). First, single-particle cryo-EM analysis does not require crystallization and avoids limitations imposed by crystal packing. Second, multiple, discrete conformational states, such as TraR-Eσ^70^(I), TraR-Eσ^70^(II), and TraR-Eσ^70^(III) ([Figure 1A,B](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), can be revealed from a single sample ([@bib7]). Third, when a conformational change does not parse into discrete states but rather comprises a continuous distribution of conformations, the range of conformational states can nevertheless be assessed experimentally ([Figures 6](#fig6){ref-type="fig"} and [7](#fig7){ref-type="fig"}) ([@bib52]).

The consequences of the TraR-induced conformational changes for promoter function (activation or inhibition) depend on the distinctly different properties of the promoters, which are attributable to differences in DNA sequence ([@bib31]; [@bib73]). Eσ^70^ can complete RPo formation on some promoters in a fraction of a second, whereas RPo's on other promoters require ten minutes or more to form. Likewise, the RPo half-life can vary greatly on different promoters, from a few minutes to many hours. The large range of promoter properties gives rise to activities of bacterial transcription initiation that vary over \~4 orders of magnitude and provide rich targets for regulation ([@bib27]; [@bib46]).

Mechanistic studies of ppGpp/DksA- and TraR-dependent regulation of initiation revealed general characteristics of promoters that are either activated or inhibited by these factors and led to a conceptual model for how they activate some promoters while inhibiting others ([@bib28]; [@bib29]; [@bib54]; [@bib56]; [@bib70]). In the absence of factors, inhibited promoters generate RPo very rapidly ([@bib60]), but the final transcription-competent RPo is relatively unstable. The half-life of RPo for the inhibited promoter *rrnB* P1 is measured in seconds or a few minutes, depending on solution conditions ([@bib8]). In the absence of either transcription factors or high initiating NTP concentrations, RPo at *rrnB* P1 exists in equilibrium with earlier intermediates along the pathway to RPo formation ([@bib28]; [@bib70]). The very short RPo half-life at inhibited promoters means that initiation of RNA chain synthesis competes with dissociation of RPo. High NTP concentrations can shift the equilibrium in favor of RPo by mass action by populating complexes that follow RPo in the transcription cycle ([@bib9]; [@bib51]).

By contrast, activated promoters generate RPo very slowly ([@bib8]; [@bib56]) but the RPo that is ultimately formed is stable. For example, the activated promoters p*argI*, p*hisG*, and p*thrABC* have RPo half-lives measured in many hours \[15 hr,\>13 hr, and 6.7 hr, respectively ([@bib8]).

In order for a transcription factor, such as TraR, to achieve differential regulation (that is, to activate some promoters but inhibit others through the same effects on RNAP), the factor must affect more than one feature of the multi-step pathway of RPo formation ([@bib27]). In our model for TraR function, TraR acts on all promoters similarly. TraR relieves kinetic barriers to accelerate RPo formation but at the same time stabilizes an intermediate prior to RPo formation ([@bib27]). Whether TraR activates or inhibits a promoter depends on the basal kinetic landscape for RPo formation at that promoter ([Figure 8](#fig8){ref-type="fig"}). As summarized below, our structural analysis of the conformational changes imparted on Eσ^70^ by TraR binding and our biochemical tests of the functional consequences suggested molecular mechanisms for the effect of TraR on the pathway to RPo formation, providing molecular insight into activation and inhibition.

![Proposed effects of TraR on the free energy diagram for hypothetical inhibited and activated promoters.\
Shown at the top is a proposed three-step linear kinetic scheme for RPo formation ([@bib33]) with an added fourth irreversible step (formation of RP~itc~) once RNA synthesis begins. (T) denotes the presence of TraR, which must dissociate to allow the transition of RPo - \> RPitc. The basal (WT-RNAP) free energy diagrams for hypothetical inhibited (top) and activated (bottom) promoters are shown in black (adapted from [@bib27] as described in Materials and methods). The proposed influence of TraR on the energy diagram (lowering the kinetic barrier for the transition RP1 ⇄ RP2; lowering the free energy of RP2 relative to RPo; lowering the kinetic barrier for the transition RP2 ⇄ RPo) is shown (inhibited promoter, red curve; activated promoter, green curve) along with proposed links with the structural effects of TraR binding to RNAP described here. The steady-state transcription output \[calculated with the transcription flux calculator ([@bib27]) is represented by the circles on the right. The precise values for the inputs and outputs for the flux calculator are tabulated in [Supplementary file 2](#supp2){ref-type="supplementary-material"}. The area inside the black circle represents the basal transcription output. The red or green circles (inhibited or activated promoters, respectively) represent the effect of TraR on the transcription output.](elife-49375-fig8){#fig8}

Structural mechanism for TraR-mediated activation {#s3-1}
-------------------------------------------------

Together, several lines of structural, biochemical, genetic and kinetic evidence, presented here or published previously, lead to a model for the structural mechanism of activation by TraR. Previous data showed that TraR or its homolog DksA (in conjunction with ppGpp) enhance the transcription output from activated promoters relative to that with RNAP alone (i.e., in the absence of factor; [@bib56]; [@bib28]). In addition, kinetic analyses demonstrated that the TraR homolog ppGpp/DksA enhances the rate and amount of RPo formation at an activated promoter ([@bib56]) primarily by increasing the rates of step(s) subsequent to RNAP binding to the promoter.

Here we show that in the absence of TraR, RNAP with a deletion of σ^70^~1.1~ displayed greatly increased promoter activity on the *thrABC* promoter relative to the activity with WT RNAP (32-fold increase; [Figure 4D](#fig4){ref-type="fig"}), indicating that the presence of σ^70^~1.1~ in the RNAP channel presents a major barrier to the formation of RPo on activated promoters. This large effect on promoter activity was not observed with *rrnB* P1, an inhibited promoter ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). These results are consistent with previous reports that deletion of σ^70^~1.1~ had different effects on different promoters, increasing RPo at some promoters but not at others ([@bib69]; [@bib32]; [@bib80]).

We suggest that σ^70^~1.1~ poses the most significant barrier to RPo formation at activated promoters, but not the only one, since addition of TraR to RNAP lacking σ^70^~1.1~ resulted in a small TraR-dependent increase in transcription of the *thrABC* promoter ([Figure 4D](#fig4){ref-type="fig"}). We suggest that this small increase could result from the restriction of clamp motion by TraR (described in the Results section) at a step prior to σ^70^~1.1~ ejection, perhaps transcription bubble nucleation ([@bib25]).

We propose that TraR binding allosterically alters and weakens σ^70^~1.1~ interactions in the RNAP channel by causing a large (\~18°) rotation of the βlobe-Si1 module that forms one wall of the channel ([Figure 4A](#fig4){ref-type="fig"}; see also [Video 1](#video1){ref-type="video"}). In addition, the interaction of TraR~G~ with the SBHMa motif of Si3 ([Figure 3](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}) may also contribute to weakening of σ^70^~1.1~ interactions with the main channel, because Si3 is inserted within the trigger loop (TL) and its interactions with TraR could perturb interactions of the TL/BH/Switch one region with σ^70^~1.1.~ Deletion of β'Si3 has been shown to reduce the lifetime of open complexes by 3--10 fold ([@bib69]), suggesting the possibility that the reduced activation observed with the Si3 deletion RNAP could also result from effects on RPo stability.

The TraR-induced conformational changes that alter and weaken σ^70^~1.1~ interactions in the main channel are proposed to facilitate displacement of σ^70^~1.1~ by promoter DNA ([Figures 1](#fig1){ref-type="fig"} and [4](#fig4){ref-type="fig"}; see also [Video 1](#video1){ref-type="video"}). However, effects of TraR on clamp conformation may also contribute to the increase in RPo by increasing bubble nucleation, as proposed by [@bib25]. Together, these effects could be sufficient to account for the TraR-dependent increase in the amount of RPo formed at an activated promoter.

Since the structural data indicate that TraR bound to the RNAP complex would sterically block initial NTP access to the active site, along with t-strand positioning and catalysis ([Figure 5](#fig5){ref-type="fig"}; see also [@bib49]), TraR must dissociate from the complex in order to allow initiation from the activated promoter. The proposal that TraR dissociates from the complex at an activated promoter prior to the dissociation of RNAP from the promoter is supported by previous data on the lifetimes of these complexes. The lifetime of RPo at activated promoters (measured in hours; [@bib8]) is much longer than the lifetime of the transcription factors on RNAP (GreB, DksA and by extension TraR; measured in seconds; [@bib77]).

The kinetics of transcription initiation are illustrated by a schematic energy landscape in [Figure 8](#fig8){ref-type="fig"}, where specific structural effects of TraR are correlated with changes in free energy at positively and negatively regulated promoters. The TraR-dependent changes in RNAP conformation and the resulting effects on σ^70^~1.1~ would lower the kinetic barrier to RPo formation. At an activated promoter, the free energy of the transition state between RP2 and RPo is rate-limiting, and it is reduced by the TraR-induced weakening of σ^70^~1.1~ interactions in the main channel, leading to an increase in transcription ([Figure 8](#fig8){ref-type="fig"}).

Structural mechanism for TraR-mediated inhibition {#s3-2}
-------------------------------------------------

TraR (and ppGpp/DksA)-inhibited promoters form RPo rapidly ([@bib60]) but their intrinsically unstable RPo results in significant population of earlier intermediates ([@bib28]; [@bib70]). Although TraR likely accelerates bubble nucleation and σ^70^~1.1~ ejection at inhibited promoters, these steps are already rapid and transcription output is not affected. In contrast to its effects on an activated promoter, deletion of σ^70^~1.1~ had much smaller effects on basal transcription and inhibition by TraR on an inhibited promoter ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}).

However, TraR binding induces two distinct conformational changes in RNAP that we propose disfavor RPo formation, accounting for inhibition. Most prominent is a direct interaction of TraR with βSi1 that leads to the 18 Å displacement of the βlobe that alters the shape of the main channel and may stabilize DNA contacts in an intermediate prior to RPo (such as RP2; [Figure 8](#fig8){ref-type="fig"}). Stabilization of an intermediate compared to RPo at inhibited promoters would have a dramatic effect on transcription output by further shifting occupancy by RNAP to earlier intermediates in the RPo formation pathway. Consistent with these hypotheses, ΔSi1-RNAP has reduced TraR-mediated inhibition ([Figure 4B](#fig4){ref-type="fig"}), and footprints with RNAP on negatively regulated promoters like *rrnB* P1 and *rpsT* P2 have a shortened downstream boundary of DNase I protection ([@bib28]).

Inhibition by TraR is multipartite. In addition to causing rotation of the βlobe-Si1, TraR binding also induces a kinked BH that sterically clashes with proper positioning of the t-strand DNA near the active site ([Figure 5](#fig5){ref-type="fig"}), as reported previously ([@bib49]). Precise positioning of the t-strand DNA at the active site is critical for efficient catalysis of phosphodiester bond formation by RNAP in the S~N~2 mechanism ([@bib82]). Occupancy of the secondary channel by TraR would be expected to block catalysis by sterically blocking TL folding required for catalysis and preventing access of initiating NTPs to the active site, ensuring that any complexes containing TraR that proceeded to RPo could not initiate transcription.

Why not attribute inhibition entirely to this ability of TraR to block iNTP access to the active site? Recent single molecule fluorescence studies ([@bib77]) indicated that secondary channel binding factors (GreB, DksA and by extension TraR) formed an RNAP-factor complex prior to binding to promoter DNA, and dissociated together with RNAP from an inhibited promoter complex (*rrnB* P1) because the lifetime of RNAP on *rrnB* P1 is shorter than the lifetime of the factors on RNAP ([@bib77]). Since the affinity of TraR for RNAP is similar to that of DksA ([@bib28]), it is likely that TraR exhibits similar properties. Binding of the factors to preformed RPo was not observed ([@bib77]), consistent with the ten-fold reduced affinity of DksA for RPo ([@bib40]). These data are consistent with our model for inhibition, suggesting that TraR would bind together with RNAP to an inhibited promoter and severely reduce RPo formation by stabilizing an intermediate ([Figure 8](#fig8){ref-type="fig"}). TraR would remain associated with the complex until RNAP dissociated. TraR\'s presence in the complex for the entire time of RNAP occupancy of the promoter would leave little opportunity for RPo to form and would also prevent catalysis by any RPo that did form.

TraR manipulates *Eco* RNAP lineage-specific insertions to modulate transcription initiation {#s3-3}
--------------------------------------------------------------------------------------------

The β and β\' subunits of the bacterial RNAP are conserved throughout evolution, containing 16 and 11 sequence regions, respectively, common to all bacterial RNAPs ([@bib38]). These shared sequence regions are separated by relatively nonconserved spacer regions in which large LSIs can occur ([@bib38]). The LSIs are typically independently-folded, highly mobile domains, ranging in size from 50 to 500 amino acids on the RNAP surface. A key feature of the mechanism of TraR function is modulation of *Eco* RNAP transcription initiation through conformational changes brought about by interactions with two of the *Eco* RNAP LSIs, βSi1 ([Figure 4A](#fig4){ref-type="fig"}) and β\'Si3 ([Figure 3A--C](#fig3){ref-type="fig"}).

*Eco* βSi1 was originally designated dispensible region 1 ([@bib76]), but its deletion reduced growth at 30 °C and prevented growth at 42°, suggesting that it might serve as a binding determinant for regulatory factors ([@bib2]). Indeed, TraR interacts with βSi1 as well as with the nearby βlobe to distort the RNAP channel ([Figure 4A](#fig4){ref-type="fig"}), effecting both inhibition ([Figure 4B](#fig4){ref-type="fig"}) and activation ([Figure 4C](#fig4){ref-type="fig"}) by TraR.

*Eco* β\'Si3 is an unusual LSI as it is inserted in the middle of the TL, a key structural element in the RNAP nucleotide addition cycle that is conserved in all multi-subunit RNAPs ([@bib38]). As a consequence, Si3 plays a central role in *Eco* RNAP function, and cells deleted for Si3 are not viable ([@bib2]; [@bib83]). Si3 is highly mobile, rotating about 33° to accommodate folding and unfolding of the TL at each RNAP nucleotide addition cycle ([@bib43]; [@bib88]). Si3 was often disordered in *Eco* RNAP crystal structures \[for example, see [@bib49]\]. In our cryo-EM analysis, TraR engages with Si3, stabilizing a previously undetected conformation of Si3 affecting activation ([Figure 3](#fig3){ref-type="fig"}). Si3 has been implicated previously in RPo formation since the Δβ\'Si3-RNAP forms an unstable RPo ([@bib2]).

Conclusion {#s3-4}
----------

TraR-like proteins are widespread in proteobacteria, related bacteriophage, and plasmids ([@bib28]; [@bib29]). While TraR function in vivo is incompletely understood, TraR engages with RNAP in much the same way as ppGpp/DksA and regulates transcription similarly. The structural and functional analyses described here identify the RNAP conformational changes responsible for the effects of TraR on transcription, deconvoluting the complicated, multifaceted mechanism that distinguishes activation from inhibition. The complex interplay between TraR binding and RNAP conformation and conformational heterogeneity allows TraR to modulate multiple features of the energy landscape of RPo formation ([Figure 8](#fig8){ref-type="fig"}), which is key to allowing TraR to effect differential regulation across promoter space without directly interacting with DNA. The very similar effects of ppGpp/DksA and TraR on RNAP function ([@bib28]; [@bib29]) suggests that DksA-ppGpp works via a similar structural mechanism.

Materials and methods {#s4}
=====================

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                Designation                                                                      Source or reference                                              Ident-ifiers         Additional\
  (species) or\                                                                                                                                                                                       information
  resource                                                                                                                                                                                            
  ---------------------------- -------------------------------------------------------------------------------- ---------------------------------------------------------------- -------------------- --------------------------------------------------------------------------------------------------------------
  Strain, strain background\   *Eco* BL21(DE3)                                                                  EMD Millipore (Burlington, MA)                                                        
  (*Escherichia coli*)                                                                                                                                                                                

  Recombinant DNA reagent      pACYCDuet-1_Ec\_*rpoZ*                                                           PMID: [21416542](https://www.ncbi.nlm.nih.gov/pubmed/21416542)                        

  Recombinant DNA reagent      pEc*rpoABC*(-XH)Z                                                                PMID: [21416542](https://www.ncbi.nlm.nih.gov/pubmed/21416542)                        

  Recombinant DNA reagent      pET28a                                                                           EMD Millipore                                                                         

  Recombinant DNA reagent      pET28a-His~10~-SUMO *rpoD*                                                       PMID: [28988932](https://www.ncbi.nlm.nih.gov/pubmed/28988932)                        

  Recombinant DNA reagent      pET28a-His~10~-SUMO *traR* (pRLG15142)                                           This paper                                                                            Encodes *Eco* TraR with N-terminal His~10~-SUMO tag (Darst lab)

  Recombinant DNA reagent      pRLG770                                                                          PMID: [2209559](https://www.ncbi.nlm.nih.gov/pubmed/2209559)                          In vitro transcription vector, AmpR

  Recombinant DNA reagent      pRLG770-*rrnB* P1 (pRLG13065)                                                    PMID: [27237053](https://www.ncbi.nlm.nih.gov/pubmed/27237053)                        *rrnB* P1 with −88 to +50 endpoints

  Recombinant DNA reagent      pRLG770-*argI* (pRLG13098)                                                       PMID: [11162084](https://www.ncbi.nlm.nih.gov/pubmed/11162084)                        p*argI* with −45 to +32 endpoints

  Recombinant DNA reagent      pRLG770-*hisG* (pRLG13099)                                                       PMID: [15899978](https://www.ncbi.nlm.nih.gov/pubmed/15899978)                        p*hisG* with −60 to +1 endpoints

  Recombinant DNA reagent      pRLG770-*rpsT* P2 (pRLG14658)                                                    PMID: [21402902](https://www.ncbi.nlm.nih.gov/pubmed/21402902)                        *rpsT* P2 with −89 to +50 endpoints

  Recombinant DNA reagent      pRLG770-*thrABC* (pRLG15276)                                                     PMID: [11162084](https://www.ncbi.nlm.nih.gov/pubmed/11162084)                        p*thrABC* with −72 to +16 endpoints

  Recombinant DNA reagent      pT7 αββ\'(Δ943--1130) (pIA331)                                                   PMID: [12511572](https://www.ncbi.nlm.nih.gov/pubmed/12511572)                        ∆Si3 RNAP

  Recombinant DNA reagent      pIA900 *rpoB* Δ225--343ΩGG (pRLG12586)                                           PMID: [28652326](https://www.ncbi.nlm.nih.gov/pubmed/28652326)                        ∆Si1 RNAP

  Recombinant DNA reagent      pET28a-His~10~-SUMO P43A *traR (*pRLG14844)                                      This paper                                                                            Encodes *Eco* TraR\[P43A\] with N-terminal His~10~-SUMO tag (Gourse lab)

  Recombinant DNA reagent      pET28a- His~10~- SUMO P45A *traR* (pRLG14846)                                    This paper                                                                            Encodes *Eco* TraR\[P45A\] with N-terminal His~10~-SUMO tag (Gourse lab)

  Recombinant DNA reagent      pET28a-His~10-~ SUMO\                                                            This paper                                                                            Encodes *Eco* TraR\[E46A\] with N-terminal His~10~-SUMO tag (Gourse lab)
                               E46A *traR* (pRLG14847)                                                                                                                                                

  Recombinant DNA reagent      pET28a-His~10~-SUMO R49A *traR* (pRLG15278)                                      This paper                                                                            Encodes *Eco* TraR\[R49A\] with N-terminal His~10~-SUMO tag (Gourse lab)

  Recombinant DNA reagent      pET28a-His~10~-SUMO K50A *traR* (pRLG15279)                                      This paper                                                                            Encodes *Eco* TraR\[K50A\] with N-terminal His~10~-SUMO tag (Gourse lab)

  Sequence-based reagent       P43A *traR*                                                                      IDT, this paper                                                                       5' GAAGCATGCGGAAATGCTATTCCGGAAGCC 3' (Gourse lab)

  Sequence-based reagent       P45A *traR*                                                                      IDT, this paper                                                                       5' GGAAATCCTATTGCGGAAGCCCGGCGG 3' (Gourse lab)

  Sequence-based reagent       E46A *traR*                                                                      IDT, this paper                                                                       5' GGAAATCCTATTCCGGCAGCCCGGCGGAAAATA 3' (Gourse lab)

  Sequence-based reagent       R49A *traR*                                                                      IDT, this paper                                                                       5' ATTCCGGAAGCCCGGGCGAAAATATTTCCCGGT 3' (Gourse lab)

  Sequence-based reagent       K50A *traR*                                                                      IDT, this paper                                                                       5' ATTCCGGAAGCCCGGCGGGCAATATTTCCCGGT 3' (Gourse lab)

  Sequence-based reagent       SumoF                                                                            IDT, this paper                                                                       5' GGGGAATTGTGAGCGGATAACAATTCC 3' (Gourse lab)

  Sequence-based reagent       SumoR                                                                            IDT, this paper                                                                       5' GTCCCATTCGCCAATCCGGATATAG 3' (Gourse lab)

  Sequence-based reagent       TraR_sumo_vector_FOR                                                             IDT, this paper                                                                       5'- AAACATTATGCATAACAAAGCCCGAAAGGAAGCTGAG −3' (Gourse lab)

  Sequence-based reagent       pETsumo_traR_vector_REV                                                          IDT, this paper                                                                       5'- CGGCTTCATCACTTCCACCAATCTGTTCTCTGTGAGCC −3' (Gourse lab)

  Sequence-based reagent       TraR_sumo_fragment_REV                                                           IDT, this paper                                                                       5'- TCGGGCTTTGTTATGCATAATGTTTTCTCTGTCTTTCCTGATACG −3' (Gourse lab)

  Sequence-based reagent       TraR_sumo_fragment_FOR                                                           IDT, this paper                                                                       5'- CAGATTGGTGGAAGTGATGAAGCCGATGAAGCATATTCAG −3' (Gourse lab)

  Sequence-based reagent       *rrnB*P1(−63 to +20) top                                                         IDT, this paper                                                                       5'- GGTCAGAAAATTATTTTAAATTTCCTCTTGTCA GGCCGGAATAACTCCCTATAATGCGCCACCACTGACACGGAACAACGGCG −3' (Darst lab)

  Sequence-based reagent       *rrnB*P1(−63 to +20) bot                                                         IDT, this paper                                                                       5'- CGCCGTTGTTCCGTGTCAGTGGTGGCGCATTAT AGGGAGTTATTCCGGCCTGACAAGAGGAAATTTAAAATAATTTTCTGACC −3' (Darst lab)

  Sequence-based reagent       *rpsT*P2(−60 to +25) top                                                         IDT, this paper                                                                       5'- GGCGGCGCTTATTTGCACAAATCCATTGACAAA AGAAGGCTAAAAGGGCATATTCCTCGGCCTTTG\
                                                                                                                                                                                                      AATTGTCCATATAGAACGC −3' (Darst lab)

  Sequence-based reagent       *rpsT*P2 (−60 to +25) bot                                                        IDT, this paper                                                                       5'- GCGTTCTATATGGACAATTCAAAGGCCGAGGAA TAT GCCCTTTTAGCCTTCTTTTGTCAATGGATTTGT GCAAATAAGCGCCGCC −3' (Darst lab)

  Chemical compound, drug      3-\[(3-Cholamidopropyl)dimethylammonio\]−2-Hydroxy-1-Propanesulfonate (CHAPSO)   Anatrace                                                         Cat\# C317           

  Software, algorithm          Bayesian Polishing                                                               PMID: [30412051](https://www.ncbi.nlm.nih.gov/pubmed/30412051)                        

  Software, algorithm          Bsoft                                                                            PMID: [23954653](https://www.ncbi.nlm.nih.gov/pubmed/23954653)                        

  Software, algorithm          Coot                                                                             PMID: [15572765](https://www.ncbi.nlm.nih.gov/pubmed/15572765)                        

  Software, algorithm          cryoSPARC                                                                        PMID: [28165473](https://www.ncbi.nlm.nih.gov/pubmed/28165473)                        

  Software, algorithm          CTFFIND4                                                                         PMID: [26278980](https://www.ncbi.nlm.nih.gov/pubmed/26278980)                        

  Software, algorithm          EMAN2                                                                            PMID: [16859925](https://www.ncbi.nlm.nih.gov/pubmed/16859925)                        

  Software, algorithm          Gautomatch                                                                       <http://www.mrc-lmb.cam.ac.uk/kzhang/Gautomatch>                                      

  Software, algorithm          Gctf                                                                             PMID: [26592709](https://www.ncbi.nlm.nih.gov/pubmed/26592709)                        

  Software, algorithm          Molprobity                                                                       PMID: [20057044](https://www.ncbi.nlm.nih.gov/pubmed/20057044)                        

  Software, algorithm          MotionCor2                                                                       PMID: [28250466](https://www.ncbi.nlm.nih.gov/pubmed/28250466)                        

  Software, algorithm          Multi-body refinement                                                            PMID: [29856314](https://www.ncbi.nlm.nih.gov/pubmed/29856314)                        

  Software, algorithm          PHENIX                                                                           PMID: [20124702](https://www.ncbi.nlm.nih.gov/pubmed/20124702)                        

  Software, algorithm          RELION                                                                           PMID: [23000701](https://www.ncbi.nlm.nih.gov/pubmed/23000701)                        

  Software, algorithm          SerialEM                                                                         PMID: [16182563](https://www.ncbi.nlm.nih.gov/pubmed/16182563)                        

  Software, algorithm          UCSF Chimera                                                                     PMID: [15264254](https://www.ncbi.nlm.nih.gov/pubmed/15264254)                        

  Software, algorithm          Unblur                                                                           PMID: [26023829](https://www.ncbi.nlm.nih.gov/pubmed/26023829)                        

  Other                        C-flat CF-1.2/1.3 400 mesh gold grids                                            Electron Microscopy Sciences                                     Cat\# CF413-100-Au   
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Strains, Plasmids and Primer sequences {#s4-1}
--------------------------------------

Plasmids are listed in [Supplementary file 4](#supp4){ref-type="supplementary-material"} and oligonucleotide and geneblock sequences are in [Supplementary file 5](#supp5){ref-type="supplementary-material"}. Bacteria were grown in LB Lennox media or on LB agar plates. Media was supplemented with ampicillin (100 µg/ml) or kanamycin (30 µg/ml) if needed. TraR was made by cloning the *traR* gene in a pET28-based His~10~-SUMO vector which allowed removal of the cleavable N-terminal His~10~-SUMO tag with Ulp1 protease. ESI-Mass Spectrometry revealed that the molecular mass of purified TraR corresponded to that of a monomer lacking the N-terminal methionine \[Figure S6 of [@bib28]\], hence *traR* without the initial M was cloned into the SUMO vector. This tag-less version of TraR exhibited the same level of activity as a previous TraR construct with four additional residues (LVPR) at the C-terminal end leftover after His~6~ tag cleavage in the TraR-thrombin site-His~6~ construct ([@bib28]).

Expression and purification of TraR for cryo-EM {#s4-2}
-----------------------------------------------

The His~10~-SUMO-TraR plasmid was transformed into competent *Eco* BL21(DE3) by heat shock. The cells were grown in the presence of 25 µg/mL kanamycin to an OD~600~ of 0.5 in a 37°C shaker. TraR expression was induced with a final concentration of 1 mM isopropyl ß-D-thiogalactopyranoside (IPTG) for 3 hr at 37°C. Cells were harvested by centrifugation and resuspended in 50 mM Tris-HCl, pH 8.0, 250 mM NaCl, 5 mM imidazole, 10% glycerol (v/v), 2.5 mM dithiothreitol (DTT), 10 µM ZnCl~2~, 1 mM phenylmethylsulfonyl fluoride (PMSF, Sigma-Aldrich, St. Louis, MO), 1x protease inhibitor cocktail (PIC, Sigma-Aldrich). Cells were homogenized using a continuous-flow French Press (Avestin, Ottawa, ON, Canada) at 4°C and the resulting lysate was centrifuged to isolate the soluble fraction. The supernatant was loaded onto two 5 mL HiTrap IMAC HP columns (GE Healthcare, Pittsburgh, PA) for a total column volume (CV) of 10 mL. His~10~-SUMO-TraR was eluted at 300 mM imidazole in Ni-column buffer \[50 mM Tris-HCl, pH 8.0, 500 mM NaCl, 10% glycerol (v/v), 10 µM ZnCl~2~, 2.5 mM DTT\]. Peak fractions were combined, treated with ULP1 SUMO-protease overnight, and dialyzed against 20 mM Tris-HCl, pH 8.0, 5% glycerol (v/v), 0.1 mM ethylenediaminetetraacetic acid (EDTA), 500 mM NaCl, 10 µM ZnCl~2~, 2.5 mM DTT, resulting in a final imidazole concentration of 25 mM. The ULP1-cleaved sample was loaded onto one 5 mL HiTrap IMAC HP column to remove His~10~-SUMO-tag along with any remaining uncut TraR. Tagless TraR was collected in the flowthrough and concentrated by centrifugal filtration (Amicon Ultra, EMD Millipore, Burlington, MA). The sample was purified in a final step on a HiLoad 16/60 Superdex 200 column (GE Healthcare). Purified TraR was concentrated to 16 mg/mL by centrifugal filtration, flash-frozen in liquid N~2~, and stored at −80°C.

*Eco* His~10~-PPX-RNAP expression and purification {#s4-3}
--------------------------------------------------

A pET-based plasmid overexpressing each subunit of RNAP (full-length α, β, ω) as well as β\'-PPX-His~10~ (PPX; PreScission protease site, LEVLFQGP, GE Healthcare) was co-transformed with a pACYCDuet-1 plasmid containing *Eco* rpoZ into *Eco* BL21(DE3). The cells were grown in the presence of 100 µg/mL ampicillin and 34 μg/mL chloramphenicol to an OD~600~ of 0.6 in a 37°C shaker. Protein expression was induced with 1 mM IPTG (final concentration) for 4 hr at 30°C. Cells were harvested by centrifugation and resuspended in 50 mM Tris-HCl, pH 8.0, 5% glycerol (v/v), 10 mM DTT, 1 mM PMSF, and 1x PIC. After French Press lysis at 4°C, the lysate was centrifuged twice for 30 min each. Polyethyleneimine \[PEI, 10% (w/v), pH 8.0, Acros Organics - ThermFisher Scientific, Waltham, MA\] was slowly added to the supernatant to a final concentration of \~0.6% PEI with continuous stirring. The mixture was stirred at 4°C for an addition 25 min, then centrifuged for 1.5 hr at 4°C. The pellets were washed three times with 50 mM Tris-HCl, pH 8.0, 500 mM NaCl, 10 mM DTT, 5% glycerol (v/v), 1 mM PMSF, 1x PIC. For each wash, the pellets were homogenized then centrifuged again. RNAP was eluted by washing the pellets three times with 50 mM Tris-HCl, pH 8.0, 1 M NaCl, 10 mM DTT, 5% glycerol (v/v), 1x PIC, 1 mM PMSF. The PEI elutions were combined and precipitated with ammonium sulfate overnight. The mixture was centrifuged and the pellets were resuspended in 20 mM Tris-HCl, pH 8.0, 1 M NaCl, 5% glycerol (v/v), 5 mM DTT. The mixture was loaded onto three 5 mL HiTrap IMAC HP columns for a total CV of 15 ml. RNAP(β\'-PPX-His~10~) was eluted at 250 mM imidazole in Ni-column buffer. The eluted RNAP fractions were combined and dialyzed against 20 mM Tris-HCl, pH 8.0, 100 mM NaCl, 5% glycerol (v/v), 5 mM DTT. The sample was then loaded onto a 35 mL Biorex-70 column (Bio-Rad, Hercules, CA), washed with 10 mM Tris-HCl, pH 8.0, 0.1 mM EDTA, 5% glycerol (v/v), 5 mM DTT\] in a gradient from 0.2 M to 0.7 M NaCl. The eluted fractions were combined, concentrated by centrifugal filtration, then loaded onto a 320 mL HiLoad 26/600 Superdex 200 column (GE Healthcare) equilibrated in gel filtration buffer \[10 mM Tris-HCl, pH 8.0, 0.1 mM EDTA, 0.5 M NaCl, 5% glycerol (v/v), 5 mM DTT\]. The eluted RNAP was supplemented with glycerol to 20% (v/v), flash frozen in liquid N~2~, and stored at −80°C.

*Eco* His~10~-SUMO-σ^70^ expression and purification {#s4-4}
----------------------------------------------------

Plasmid encoding *Eco* His~10~-SUMO-σ^70^ was transformed into *Eco* BL21(DE3) by heat shock. The cells were grown in the presence of 50 µg/mL kanamycin to an OD~600~ of 0.6 at 37°C. Protein expression was induced with 1 mM IPTG for 1 hr at 30°C. Cells were harvested by centrifugation and resuspended in 20 mM Tris-HCl, pH 8.0, 5% glycerol (v/v), 500 mM NaCl, 0.1 mM EDTA, 5 mM imidazole, 0.5 mM 2-mercaptoethanol (BME), 1 mM PMSF, 1x PIC. After French Press lysis at 4°C, cell debris was removed by centrifugation. The lysate was loaded onto two 5 mL HiTrap IMAC HP for a total CV of 10 ml. His~10~-SUMO-σ^70^ was eluted at 250 mM imidazole in 20 mM Tris-HCl, pH 8.0, 500 mM NaCl, 0.1 mM EDTA, 5% glycerol (v/v), 0.5 mM BME. Peak fractions were combined, cleaved with ULP1, and dialyzed against 20 mM Tris-HCl pH 8.0, 500 mM NaCl, 0.1 mM EDTA, 5% glycerol (v/v), 0.5 mM BME, resulting in a final imidazole concentration of 25 mM. The cleaved sample was loaded onto one 5 mL HiTrap IMAC HP to remove His~10~-SUMO-tag along with any remaining uncut σ^70^. Tagless σ^70^ was collected in the flowthrough and concentrated by centrifugal filtration. The sample was then loaded onto a HiLoad 16/60 Superdex 200 in gel filtration buffer. Peak fractions of σ^70^ were pooled, supplemented with glycerol to a final concentration of 20% (v/v), flash-frozen in liquid N~2~, and stored at −80°C.

Preparation of Eσ^70^ for cryo-EM {#s4-5}
---------------------------------

Eσ^70^ was formed by mixing purified RNAP and 2.5-fold molar excess of σ^70^ and incubating for 20 min at 37°C. Eσ^70^ was purified on a Superose 6 Increase 10/300 GL column (GE Healthcare) in gel filtration buffer (10 mM Tris-HCl, pH 8.0, 200 mM KCl, 5 mM MgCl~2~, 10 µM ZnCl~2~, 2.5 mM DTT). The eluted Eσ^70^ was concentrated to \~10 mg/mL (\~21 μM) by centrifugal filtration (Amicon Ultra).

Preparation of TraR-Eσ^70^ for cryo-EM {#s4-6}
--------------------------------------

Eσ^70^ was formed by mixing purified RNAP and a 2-fold molar excess of σ^70^ and incubating for 15 min at room temperature. Eσ^70^ was purified over a Superose 6 Increase 10/300 GL column in gel filtration buffer. The eluted Eσ^70^ was concentrated to \~5.0 mg/mL (\~10 μM) by centrifugal filtration. Purified TraR was added (5-fold molar excess over RNAP) and the sample was incubated for 15 min at room temperature. An *rrnB* P1 promoter fragment (Integrated DNA Technologies, Coralville, IA) was added (2-fold molar excess over RNAP) and the sample was incubated for a further 15 min at room temperature. The *rrnB* P1 promoter fragment did not bind to TraR-Eσ^70^ under the cryo-EM grid preparation conditions - the subsequent structural analyses did not reveal any evidence of promoter binding.

Preparation of *rpsT* P2-RPo for cryo-EM {#s4-7}
----------------------------------------

Eσ^70^ was prepared as described for TraR-Eσ^70^, but after the size exclusion chromatography the complex was concentrated to \~10 mg/mL (\~20 μM) by centrifugal filtration. Duplex *rpsT* P2 promoter fragment (−60 to +25, [Figure 2A](#fig2){ref-type="fig"}, IDT) was added to the concentrated Eσ^70^ to 3-fold molar excess. The sample was incubated for 20 mins at room temperature prior to cryo-EM grid preparation.

Cryo-EM grid preparation {#s4-8}
------------------------

CHAPSO {3-(\[3-cholamidopropyl\]dimethylammonio)−2-hydroxy-1-propanesulfonate} (Anatrace, Maumee, OH) was added to the samples to a final concentration of 8 mM ([@bib20]). The final buffer condition for all the cryo-EM samples was 10 mM Tris-HCl, pH 8.0, 100 mM KCl, 5 mM MgCl~2~, 10 μM ZnCl~2~, 2.5 mM DTT, 8 mM CHAPSO. C-flat holey carbon grids (CF-1.2/1.3-4Au) were glow-discharged for 20 s prior to the application of 3.5 μL of the samples. Using a Vitrobot Mark IV (FEI, Hillsboro, OR), grids were blotted and plunge-froze into liquid ethane with 100% chamber humidity at 22°C.

Acquisition and processing of TraR-Eσ^70^ cryo-EM dataset {#s4-9}
---------------------------------------------------------

Grids were imaged using a 300 keV Krios (FEI) equipped with a K2 Summit direct electron detector (Gatan, Pleasanton, CA). Datasets were recorded with Serial EM ([@bib45]) with a pixel size of 1.3 Å over a defocus range of 0.8 μm to 2.4 μm. Movies were recorded in counting mode at eight electrons/physical pixel/second in dose-fractionation mode with subframes of 0.3 s over a 15 s exposure (50 frames) to give a total dose of 120 electrons/physical pixel. Dose-fractionated movies were gain-normalized, drifted-corrected, summed, and dose-weighted using MotionCor2 ([@bib30]; [@bib85]). CTFFIND4 ([@bib62]) was used for contrast transfer function estimation. Particles were picked using Gautomatch (<http://www.mrc-lmb.cam.ac.uk/kzhang/>) using a 2D template. Picked particles were extracted from the dose-weighted images with RELION ([@bib86]) using a box size of 256 pixels. Two TraR-Eσ^70^ datasets were collected: dataset 1 consisted of 1546 motion-corrected images with 631,880 particles and dataset 2 consisted of 2132 motion-corrected images with 378,987 particles. The particles from each dataset were curated using RELION 3D classification (N = 3) using a cryoSPARC ab-initio reconstruction ([@bib59]) generated from a subset of the particles. The highest resolution classes from each dataset were subjected to RELION 3D auto-refinement resulting in a 4.69 Å resolution map from dataset 1 and a 4.38 Å resolution map from dataset 2. Refinement metadata and post-processing were used as inputs for RELION CTF refinement and Bayesian Polishing ([@bib86]). The polished particles from both datasets were combined, resulting in 372,670 particles. The particles were aligned using RELION 3D auto-refinement resulting in a consensus map with nominal resolution of 3.62 Å. Using the refinement parameters, subtractive 3D classification (N = 3) was performed on the particles by subtracting density outside of β\'Si3 and classifying in a mask around β\'Si3. Classification revealed three distinct β\'Si3 dispositions (Figure S1D). Local refinement metadata (highlighted in red dotted box, Figure S1D) for TraR-Eσ^70^(I) and TraR-Eσ^70^(II) were used for RELION multi-body refinements to examine clamp motions ([@bib52]). Local resolution calculations were performed using blocres and blocfilt from the Bsoft package ([@bib16]).

Acquisition and processing of Eσ^70^ cryo-EM dataset {#s4-10}
----------------------------------------------------

The Eσ^70^ image acquisition and processing were the same as for TraR-Eσ^70^ except with the following differences. Grids were imaged using a 200 keV Talos Arctica (FEI) equipped with a K2 Summit direct electron detector. Datasets were recorded with a pixel size of 1.3 Å over a defocus range of −1.0 μm to −2.5 μm. Movies were recorded in counting mode at 8.4 electrons/physical pixel/second in dose-fractionation mode with subframes of 0.2 s over a 10 s exposure (50 frames) to give a total dose of 84 electrons/physical pixel. Picked particles were extracted from the dose-weighted images in RELION ([@bib74]) using a box size of 200 pixels. The Eσ^70^ dataset consisted of 3548 motion-corrected images with 1,387,166 particles. A subset of the particles was subjected to cryoSPARC ab-initio reconstruction ([@bib59]) to generate a 3D template for 3D classifications in cryoSPARC and 3D refinements in RELION (Scheres 2012). Particles were split into two groups (1^st^ group: particles from images 1-2,000; 2^nd^ group: particles from images 2001--3548. Particles from each group were curated using cryoSPARC heterogeneous refinement (N = 3) resulting in a subset of 479,601 particles for the first group and 329,293 particles for the second group. Curated particles were combined and a consensus refinement was performed in RELION using the cryoSPARC generated initial model resulting in a map with nominal resolution of 4.54 Å (without post-processing). Particles from this refinement (highlighted in red dotted box, [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}) were further analyzed using RELION multi-body refinement as described in the text ([@bib52]). Additionally, particles were further curated using RELION 3D classification (N = 3) without alignment. Classification revealed two lower resolution class and a higher resolution class. The higher resolution class containing 358,725 particles was RELION 3D auto-refined and subjected to RELION CTF refinement and RELION Bayesian Polishing ([@bib86]). After polishing, particles were refined to a nominal resolution of 4.05 Å after RELION post-processing.

Acquisition and processing of *rpsT* P2-RPo cryo-EM dataset {#s4-11}
-----------------------------------------------------------

The *rpsT* P2-RPo cryo-EM image acquisition and processing were the same as for TraR-Eσ^70^ except with the following differences. The imaging defocus range was 0.5 μm to 2.5 μm. Movies were recorded in super-resolution mode at eight electrons/physical pixel/second in dose-fractionation mode with subframes of 0.2 s over a 10 s exposure (50 frames) to give a total dose of 80 electrons/physical pixel. The *rpsT* P2-RPo dataset consisted of 6912 motion-corrected images with 973,481 particles. In RELION, a consensus refinement was performed using the extracted particles and a cryoSPARC generated initial model resulting in a 4.62 Å resolution map. Using the refinement parameters, 3D classification (N = 2) was performed on the particles without alignment. Classification revealed a lower resolution class and a higher resolution class, the latter with 370,965 particles with nominal resolution of 4.38 Å after RELION 3D auto-refinement. Refinement metadata and post-processing were used as inputs for RELION CTF refinement and RELION Bayesian Polishing ([@bib86]). Subsequent 3D classification (N = 3) was used to further classify the polished particles resulting in one junk class and two high-resolution classes ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). The highest resolution reconstruction (3.43 Å) contained 289,679 particles.

Model building and refinement of cryo-EM structures {#s4-12}
---------------------------------------------------

To build initial models of the protein components of the complexes, a crystal structure of *Eco* Eσ^70^ \[PDB ID 4LJZ, with σ^70^~1.1~ from 4LK1; ([@bib3]) was manually fit into the cryo-EM density maps using Chimera ([@bib58]) and manually adjusted using Coot ([@bib23]). For TraR-Eσ^70^, σ^70^~1.1~ from 4LK1 ([@bib3]) and TraR from 5W1S ([@bib49]) were also added. For *rpsT* P2-RPo, the promoter DNA was manually added. Appropriate domains of each complex were rigid-body refined, then subsequently refined with secondary structure and nucleic acid restraints using PHENIX real-space refinement ([@bib1]).

Purification of TraR and RNAP for transcription assays {#s4-13}
------------------------------------------------------

IPTG (1 mM final) was used to induce expression of TraR (WT or variant) from *Eco* BL21 DE3 *dksA*::Tn10 (RLG7075) host cells. TraR and variants were purified as described ([@bib28]), either from His~6~-TraR overexpression plasmids with removal of the His~6~-tag with thrombin, or from His~10~-SUMO-TraR constructs with removal of the His~10~-SUMO-tag with Ulp1 protease, resulting in a 72 amino acid TraR lacking the N-terminal Met. WT-TraR purified by the two methods gave comparable results. WT and variant RNAPs were purified as described previously ([@bib67]). The Δ1.1σ^70^ was expressed and purified as described previously ([@bib19]). EΔ1.1σ^70^ was reconstituted with a 4:1 molar ratio of Δ1.1σ^70^ to core RNAP. The purified core RNAP lacked detectable WT-σ^70^ activity.

In vitro transcription assays, site-directed mutagenesis, and TraR-RNAP binding assays {#s4-14}
--------------------------------------------------------------------------------------

All of these procedures were carried out exactly as previously described ([@bib28]).

Details of flux calculator calculations {#s4-15}
---------------------------------------

We modeled the hypothesized effects of RNAP mutants (Δ1.1σ^70^) or TraR on the energy diagram for transcription initiation using the flux calculator developed by [@bib27]. Since the relevant rate constants for promoters inhibited or activated by TraR are not known, the energy diagrams illustrating the kinetic/energetic schemes for transcription initiation from a hypothetical inhibited and activated promoter ([Figure 4---figure supplement 1C](#fig4s1){ref-type="fig"}, [Figure 8](#fig8){ref-type="fig"}) are meant to only qualitatively illustrate features of the promoters and the effects of manipulations \[either σ^70^~1.1~ deletion ([Figure 4---figure supplement 1C](#fig4s1){ref-type="fig"}) or addition of TraR ([Figure 8](#fig8){ref-type="fig"})\]. We hypothesize that TraR influences multiple steps along the RPo formation pathway so we wanted to model RPo formation as a three-step linear mechanism ([@bib15]; [@bib61]; [@bib75]; [@bib70]; [@bib68]; [@bib33]) rather than the two-step mechanism used in the flux calculator ([@bib27]). However, a kinetic analysis of ppGpp/DksA activation on the p*argI* promoter revealed only a very small (\<2 fold) effect on *K*~B~ (the equilibrium constant for the initial step of RNAP binding to the free promoter) and a large effect on subsequent isomerization rates (\~16 fold; [@bib56]). Similarly, activation by TraR at low and high (saturating) concentrations of RNAP gave the same fold activation on the p*thrABC* promoter, indicating TraR also does not affect the initial binding step. We make the assumption that deletion of σ^70^~1.1~ also would not dramatically affect the initial binding step. Therefore, the initial binding step (R + P ⇄ RP1) was included in the illustrations of the kinetic scheme but did not need to be accounted for in the calculations of fold-inhibition or fold-activation because deletion of σ^70^~1.1~ or addition of TraR has no effect on this step. In this way, the rate constants for the first step of the flux calculator (k~on~ and k~off~; [@bib27]) could be used as the rate constants for the second step of our kinetic scheme (k~2~ and k~-2~; [Figure 4---figure supplement 1C](#fig4s1){ref-type="fig"}; [Figure 8](#fig8){ref-type="fig"}) and so on. The precise values used in the calculations are tabulated in [Supplementary file 2](#supp2){ref-type="supplementary-material"}. The illustrations ([Figure 4---figure supplement 1C](#fig4s1){ref-type="fig"}; [Figure 8](#fig8){ref-type="fig"}) were not taken directly from the flux calculator ([@bib27]) but have been skewed vertically to make the differences between the inhibited and activated promoter easier to visualize.
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Data availability {#s7}
=================

The cryo-EM density maps have been deposited in the EMDataBank under accession codes EMD-0348 \[Eco TraR-Eσ70(I)\], EMD-0349 \[Eco TraR-Eσ70(II)\], EMD-20231 \[Eco TraR-Eσ70(III)\], EMD-20230 (Eco Eσ70), EMD-20203 (rpsT P2-RPo), and EMD-20232 (rpsT P2-RPo2). The atomic coordinates have been deposited in the Protein Data Bank under accession codes 6N57 \[Eco TraR-Eσ70(I)\], 6N58 \[Eco TraR-Eσ70(II)\], 6P1K (Eco Eσ70), and 6OUL (rpsT P2-RPo).

The following datasets were generated:

ChenJChiuCCampbellEADarstSA2019E. coli TraR-Esigma70(I)EMDataResourceEMD-0348

ChenJChiuCCampbellEADarstSA2019E. coli TraR-Esigma70(II)EMDataResourceEMD-0349

ChenJChiuCCampbellEADarstSA2019E. coli TraR-Esigma70(III)EMDataResourceEMD-20231

ChenJChiuCCampbellEADarstSA2019E. coli Esigma70EMDataResourceEMD-20230

ChenJChiuCCampbellEADarstSA2019E. coli Esigma70-rpsT P2 RPo(I)EMDataResourceEMD-20203

ChenJChiuCCampbellEADarstSA2019E. coli Esigma70-rpsT P2 RPo(II)EMDataResourceEMD-20232

ChenJChiuCCampbellEADarstSA2019E. coli TraR-Esigma70(I)RCSB Protein Data Bank6N57

ChenJChiuCCampbellEADarstSA2019E. coli TraR-Esigma70(II)RCSB Protein Data Bank6N58

ChenJChiuCCampbellEADarstSA2019E. coli Esigma70RCSB Protein Data Bank6P1K

ChenJChiuCCampbellEADarstSA2019E. coli Esigma70-rpsT P2 RPo(I)RCSB Protein Data Bank6OUL

The following previously published datasets were used:

BaeBDarstSA2013Crystal structure analysis of the E. coli holoenzymeRCSB Protein Data Bank4LJZ

BaeBDarstSA2013Crystal structure analysis of the E. coli holoenzymeRCSB Protein Data Bank4LK1

MurakamiKSMolodtsovV2017X-ray crystal structure of Escherichia coli RNA polymerase and TraR complexRCSB Protein Data Bank5W1S

MurakamiKS2015X-ray crystal structur of Escherichia coli RNA polymerase sigma70 holoenzymeRCSB Protein Data Bank4YG2
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Thank you for submitting your article \"*E. coli* TraR allosterically regulates transcription initiation by altering RNA polymerase conformation and dynamics\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Gisela Storz as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Dong Wang (Reviewer \#1).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

In the present manuscript, Darst and colleagues use cryo-electron microscopy to determine how TraR, a bacterial transcription factor related to the ppGpp-response factor DksA, regulates RNA polymerase function. Structures of *E. coli* RNAP and σ-70, with or without TraR, and of RNAP•σ-70 bound to a TraR-repressed promoter are presented. The authors find that upon binding of TraR, substantial conformational changes occur in RNAP that account for TraR\'s function. These changes are not seen in previous crystallographic analysis, which may have been limited by crystal packing constraints, and indicate that TraR modulates RNAP transcription initiation by binding and altering the conformation and dynamics of the polymerase. TraR-induced transitions are further shown by biochemical analyses to be critical for transcription activation or inhibition, depending on the kinetic features of regulated promoters. Taken together, a detailed mechanism is presented for how binding of TraR alters RNAP conformation and dynamics and to modulate the energy landscape of polymerase-promoter formation and transcription initiation.

The structural work is of significant interest, as the physical mechanisms through which TraR factor (and other transcription factors which bind directly to RNAP) regulate the kinetics of transcription initiation are poorly understood. The manuscript is clearly written and represents a nice example of the growing power of cryo-EM for the analysis of transcription complexes and their regulation. The work should be of general interest to scientists who work in transcription field; however, several issues need to be addressed before a decision on publication can be made.

Essential revisions:

1\) One issue is that no structure of TraR bound to an initiation complex is provided. The authors mention in the Materials and methods that they were unable to obtain a DNA-bound complex of TraR-RNAP in the cryo-EM. This is unfortunate, as the conformational changes that occur in the presence of DNA will be important for fully defining the structural mechanism of TraR. The lack of a structure is puzzling, since it is shown that TraR is active under the cryo-EM conditions (Figure 1---figure supplement 1A). This raises some concerns that the cryo-EM conditions allow TraR-RNAP interactions and subsequent conformational changes, but that these changes are not congruent with those that are required to support DNA binding. In addition, there is a degree of speculation on this issue in the Discussion that does not seem fully substantied in lieu of a DNA-bound TraR-RNAP complex. Some commentary on this point is needed. It is also recommended that the authors tone down some of the language on this point.

2\) Based on its blocking of the NTP-entry channel, a TraR-bound complex would be, by definition, a repressed complex for initiation. It is less clear how this fact impacts the interpretation of the kinked bridge helix as a mechanism of repression. A simpler model (related to the one laid out in the last paragraph of the Discussion) may be that activation/repression is dictated solely by the lifetime of RPo in the absence of NTPs. In a potentially interesting synthesis, could it be that the BH clash results in a very low affinity between TraR and RPo, which might also explain the inability to obtain TraR RPo structures? If so, it may be that forming TraR-RPc complexes with DNA at low temperature (4C) prior to freezing for cryo-EM would reveal closed complexes with TraR bound. Here, formation of RPo would have a large negative linkage with TraR binding and formation of RPo would eject TraR in much the way as it ejects σ1.1. This hypothesis could also directly tested by comparing the affinity of TraR to RNAP alone and preformed RNAP RPo with mismatched DNA.

3\) In multiple instances, the manuscript suggests links between structural observations and kinetics or dynamics. However, these links are hypothetical, as no time-dependent data are presented; the observed conformational heterogeneity (which is well-characterized here) may not necessarily be truly dynamic. This mis-conception is strengthened by wording throughout the paper, exemplified by the following in the Introduction, \"...new software tools allow for the analysis of molecular motions in the cryo-EM data...\" and from the Abstract, \"that quantitative analysis of RNAP conformational heterogeneity revealed TraR-induced changes in RNAP dynamics.\" While it is accepted that motions are implied by the heterogeneity, the language connecting these two phenomena should be more nuanced.

4\) The authors state that, \"dampening of motion extent is proposed to facilitate the \"nucleation of strand opening\". But the referenced manuscript (Feklistov, 2017) proposes that motions between cRNAP and oRNAP are important for strand opening, stating: \"Thus, −11 base-pair perturbations obviate the requirement for cRNAP, confirming that transient clamp closure nucleates melting,\" and \"−10 element recognition by cRNAP nucleates melting, followed by transition into oRNAP form, allowing DNA loading and unwinding in the cleft; the final closure seals the promoter complex.\" Based on the model presented in Figure 4 of Feklistov, 2017, it would seem that restricting the ability to form oRNAP may activate or inhibit strand separation depending on the kinetics of RP1-RP2-RPo. Please comment.

5\) There is not a clear synthesis of the variety of inferred structural effects on initiation. How are the effects on the clamp, the bridge helix, and the SLIs integrated to produce activation or inhibition? A kinetic model/schematic that concretely summarizes the kinetic and structural hypotheses for the reader in the context of transitions between different intermediate structures would go a long way to clarifying and synthesizing the proposed TraR model.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for submitting your article \"*E. coli* TraR allosterically regulates transcription initiation by altering RNA polymerase conformation\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Gisela Storz as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Dong Wang (Reviewer \#1).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.ß

Summary:

There are still a few questions surrounding the work, mostly with respect to the description of a mechanism for activation. These aspects of the manuscript require some attention.

Essential revisions:

1\) It would seem from the response that the authors are preparing a subsequent manuscript that will directly address the issue of the mechanism bound to initiation complexes, and that this may be considerably more complicated than the effects of TraR on the polymerase alone. Given that the paper pertains to the mechanism of TraR-based regulation, it is important to delineate how the present work, in particular the molecular mechanisms in the Discussion, stands on its own in absence of the DNA-bound models. In particular, to what extent will the observations described here be relevant after the second paper comes out?

2\) The response states that the mechanism of inhibition is due to the trapping of an early bound intermediate on repressed promoters. It is also mentioned that on these promoters, bound complexes are short lived and that TraR will likely be present for the entirety of the time. This seems sensible. However, it is also claimed that \"Due to differences in the rate-determining steps at inhibited vs. activated promoters, again described in the Discussion, TraR facilitates rather than inhibits RPo formation at activated promoters. The longer lifetime of the open complex at these promoters results in dissociation of TraR before RNAP dissociates from the promoter, allowing NTP entry and catalysis to proceed.\" In addition, the response states that \"In brief, on activated promoters with long RPo lifetime, TraR would be expected to dissociate from the promoter complex before RNAP would dissociate from the promoter, leaving ample time for activation to occur.\"

The proposed logic for activation is unclear. How can TraR activate transcription via early dissociation? What is \"ample time for activation to occur?\" After it leaves, one might expect that transcription would be de-repressed to basal levels -- not activated. Also, relative to the landscapes shown in Figure 8: these are showing landscapes in the presence and absence of a factor, and factor dissociation during the process is not modeled. It is unclear how the landscapes relate to the hypothesis for activation. Please clarify these points in the manuscript.

3\) The description of the mechanism via the use of energy landscapes has the potential to greatly clarify the hypotheses made and is a strong addition to the paper. The kinetic/thermodynamic features of the activated and repressed promoters are important should be described in the paper. It seems that one critical component may be the rate of escape. In addition, please provide details on how the flux calculator from Galburt et al. was adapted to a four-state scheme. The on-line calculator appears to only have three states.

4\) The promoters shown as examples for activated-and-repressed (Figure 8), or as activated-but-no-effect (Figure 4---figure supplement 1) appear to differ in the rate of promoter escape, which is not mentioned in the manuscript. Could the effect of promoter escape rate revealed by the landscapes be the determinant for TraR-based activation/repression? The landscapes need to be described quantitatively so as to allow others to recapitulate the results. Please comment/clarify.

5\) There is prior work on the role of different polymerase domains on initiation intermediates (Ruff et al., 2015) that should probably be considered.

10.7554/eLife.49375.sa2

Author response

> Essential revisions:
>
> 1\) One issue is that no structure of TraR bound to an initiation complex is provided. The authors mention in the Materials and methods that they were unable to obtain a DNA-bound complex of TraR-RNAP in the cryo-EM. This is unfortunate, as the conformational changes that occur in the presence of DNA will be important for fully defining the structural mechanism of TraR. The lack of a structure is puzzling, since it is shown that TraR is active under the cryo-EM conditions (Figure 1---figure supplement 1A). This raises some concerns that the cryo-EM conditions allow TraR-RNAP interactions and subsequent conformational changes, but that these changes are not congruent with those that are required to support DNA binding. In addition, there is a degree of speculation on this issue in the Discussion that does not seem fully substantied in lieu of a DNA-bound TraR-RNAP complex. Some commentary on this point is needed. It is also recommended that the authors tone down some of the language on this point.

We were unable to form a TraR-RNAP-promoter DNA complex with an *rrnB* P1 promoter fragment, as mentioned in the Materials and methods. We have subsequently obtained cryo-EM structures of TraR-RNAP-promoter DNA complexes using the *rpsT* P2 promoter fragment (Figure 2A). Both *rrnB* P1 and *rpsT* P2 are inhibited by TraR. The *rrnB* P1 promoter is known to form a very unstable complex with RNAP with a very short half-life, which is further inhibited by TraR. The *rpsT* P2 promoter also forms relatively unstable complexes but more stable than *rrnB* P1 (Gopalkrishnan et al., 2017, Gourse et al., 2018), consistent with our results. Our study of the TraR-RNAP-*rpsT* P2 complexes has revealed 7 new structures that represent intermediates along the pathway of RPo formation -- adequately addressing this work here is way beyond the scope of this manuscript and is the subject of a separate manuscript submitted elsewhere. Nevertheless, the cryo-EM conditions and subsequent conformational changes support DNA binding. Here we focus on conformational changes that TraR induces by binding to RNAP, which provide structure-based hypotheses for the differential effects of TraR on transcription initiation (activation of some promoters, inhibition of others). These hypotheses are then tested with biochemical experiments.

In response to this and other reviewer comments, we have completely re-written and re-organized the Discussion section.

> 2\) Based on its blocking of the NTP-entry channel, a TraR-bound complex would be, by definition, a repressed complex for initiation. It is less clear how this fact impacts the interpretation of the kinked bridge helix as a mechanism of repression. A simpler model (related to the one laid out in the last paragraph of the Discussion) may be that activation/repression is dictated solely by the lifetime of RPo in the absence of NTPs. In a potentially interesting synthesis, could it be that the BH clash results in a very low affinity between TraR and RPo, which might also explain the inability to obtain TraR RPo structures? If so, it may be that forming TraR-RPc complexes with DNA at low temperature (4C) prior to freezing for cryo-EM would reveal closed complexes with TraR bound. Here, formation of RPo would have a large negative linkage with TraR binding and formation of RPo would eject TraR in much the way as it ejects σ1.1. This hypothesis could also directly tested by comparing the affinity of TraR to RNAP alone and preformed RNAP RPo with mismatched DNA.

The reviewer raises several interesting and important questions that are relevant to the complexity of the regulatory mechanism employed by TraR. We revised the Discussion, especially the sections entitled "Structural Mechanisms of Activation by TraR" and "Structural Mechanisms of Inhibition by TraR", to address these questions and to describe our model more comprehensively. We also address these issues by pointing out specific data presented here, as well as in previous publications, that support our model, and we added a new figure (Figure 8) to summarize features of the model.

Specifically, we address the questions raised as follows:

2a) *'Based on its blocking of the NTP-entry channel, a TraR-bound complex would be, by definition, a repressed complex for initiation.\'*

Yes, we agree that a TraR-bound complex would be repressed for initiation, and this would be true whether the promoter is a negatively or positively regulated one. Thus, this cannot be the mechanism for activation. For the following reasons (also outlined in the Discussion) we do not think that blocking of NTP entry is the primary mechanism for inhibition.

Due to the TraR- induced conformational changes in RNAP (detailed in our paper) that severely reduce RPo formation by stabilizing an earlier intermediate on the pathway and by weakening duplex DNA interactions at inhibited promoters, transcription initiation is blocked before the stage of NTP entry and catalysis. Footprints of negatively-regulated promoter complexes containing TraR display protection from DNaseI characteristic of earlier intermediates rather than RPo, consistent with this interpretation.

Our earlier data (Lennon et al., 2009) showed that DksA (and by extension, its homolog TraR) has 10-fold reduced binding affinity for RPo relative to RNAP holoenzyme. Consistent with these data, recent single molecule fluorescence data from Gelles and colleagues (Stumper et al., 2019) showed that secondary channel binding factors (specifically GreB and DksA) bind to RNAP to form an RNAP-factor complex, before RNAP binds to the promoter, and the factors remain bound to RNAP on the promoter until RNAP dissociates. On negatively-regulated promoters like *rrnB* P1, which form extraordinarily short-lived promoter complexes with RNAP, the lifetime of the factor with RNAP is longer than the lifetime of RNAP with the promoter.

Due to differences in the rate-determining steps at inhibited vs. activated promoters, again described in the Discussion, TraR facilitates rather than inhibits RPo formation at activated promoters. The longer lifetime of the open complex at these promoters results in dissociation of TraR before RNAP dissociates from the promoter, allowing NTP entry and catalysis to proceed.

2b) *\'It is less clear how this fact impacts the interpretation of the kinked bridge helix as a mechanism of repression. A simpler model (related to the one laid out in the last paragraph of the Discussion) may be that activation/repression is dictated solely by the lifetime of RPo in the absence of NTPs.\'*

We agree with the reviewer that the lifetime of RPo is an important determinant of whether a promoter is activated or repressed, as described above, but we think that it is part of a more complex multistep mechanism. We propose that kinking of the bridge helix (BH) plays a role in the mechanism of inhibition by reducing the stability and occupancy of RPo by preventing a template strand interaction with the BH. In addition, the template strand-BH interaction correctly positions the template strand in the active site, and a BH kink would therefore inhibit catalysis. We suggest while most RNAP-TraR complexes at an inhibited promoter would not proceed to forming an open complex, the small fraction that do would be inhibited by the BH kink and restriction of NTP access, thus ensuring efficient inhibition.

2c) *'In a potentially interesting synthesis, could it be that the BH clash results in a very low affinity between TraR and RPo, which might also explain the inability to obtain TraR RPo structures?\'*

Yes, this idea is supported by our previous observation of a 10-fold reduced affinity of DksA, a TraR homolog, for a pre-formed RPo (Lennon et al., 2009). Since TraR has a similar affinity for RNAP (Gopalkrishnan et al., 2017), we propose that TraR also has a reduced affinity for pre-formed RPo. We suggest that RPo formation can occur in a small fraction of complexes in the presence of bound TraR, and that blocking catalysis would be part of a multipartite mechanism that would ensure efficient inhibition of this small fraction of complexes.

2d) *\'If so, it may be that forming TraR-RPc complexes with DNA at low temperature (4C) prior to freezing for cryo-EM would reveal closed complexes with TraR bound. Here, formation of RPo would have a large negative linkage with TraR binding and formation of RPo would eject TraR in much the way as it ejects σ1.1. This hypothesis could also directly tested by comparing the affinity of TraR to RNAP alone and preformed RNAP RPo with mismatched DNA.\'*

Several different TraR-RNAP-promoter complexes formed with DNA templates containing or lacking mismatches have been analyzed using single particle cryo EM. These results identify the structures of several different intermediates in the RPo formation pathway. Their description is beyond the scope of the present manuscript and is being reported elsewhere.

> 3\) In multiple instances, the manuscript suggests links between structural observations and kinetics or dynamics. However, these links are hypothetical, as no time-dependent data are presented; the observed conformational heterogeneity (which is well-characterized here) may not necessarily be truly dynamic. This mis-conception is strengthened by wording throughout the paper, exemplified by the following in the Introduction, \"...new software tools allow for the analysis of molecular motions in the cryo-EM data...\" and from the Abstract, \"that quantitative analysis of RNAP conformational heterogeneity revealed TraR-induced changes in RNAP dynamics.\" While it is accepted that motions are implied by the heterogeneity, the language connecting these two phenomena should be more nuanced.

There are two types of conformational heterogeneity characterized by cryo-EM in this study -- we can call them digital and analog:

I\) Digital -- The complexes exist in relatively discrete conformational states that can be parsed using the software tools in RELION. These are represented here by TraR-Eσ^70^(I) and TraR-Eσ^70^(II), where the two consensus structures differ in the disposition of β\'Si3, which is seen in two discrete positions (Figures 1A, B).

II\) Analog -- Within these classes of particles \[TraR-Eσ^70^(I) and TraR-Eσ^70^(II)\], the RNAP clamp is also conformationally heterogeneous but does not parse into discrete bins. Rather, the clamp positions are characterized by continuous \~Gaussian distributions (Figure 6B-D).

A \'digital\' conformational heterogeneity would be characterized by lifetimes of the discrete states that are long compared to the freezing time of the sample on the grid (unknown, but probably \~10 μs), while the \'analog\' conformational heterogeneity would have lifetimes of any particular conformation short compared to the freezing time. Although both types of conformational heterogeneity are almost certainly dynamic on some time scale, the reviewers comments appear to relate to the \'analog\' conformational heterogeneity observed for the RNAP clamp. It seems that the reviewer is suggesting that the continuous \~Gaussian distributions of RNAP clamp positions observed here in the frozen cryo-EM samples do not represent dynamic motions in solution that were trapped during the freezing process, but instead represent static conformational states; this seems inconceivable to us. This is supported by the finding of dynamic clamp behavior by single-molecule FRET (Duchi et al., 2018), which we have noted now in the manuscript (subsection "TraR binding restricts the range of clamp positions in Eσ^70^", first paragraph). Nevertheless, we have removed mentions of clamp \'dynamics\' or \'motions\' and replaced these with \'conformational heterogeneity\' or other wording, including in the Title, in the Abstract, as well as in the Results, and in the (rewritten) Discussion.

> 4\) The authors state that, \"dampening of motion extent is proposed to facilitate the \"nucleation of strand opening\". But the referenced manuscript (Feklistov, 2017) proposes that motions between cRNAP and oRNAP are important for strand opening, stating: \"Thus, −11 base-pair perturbations obviate the requirement for cRNAP, confirming that transient clamp closure nucleates melting,\" and \"−10 element recognition by cRNAP nucleates melting, followed by transition into oRNAP form, allowing DNA loading and unwinding in the cleft; the final closure seals the promoter complex.\" Based on the model presented in Figure 4 of Feklistov, 2017, it would seem that restricting the ability to form oRNAP may activate or inhibit strand separation depending on the kinetics of RP1-RP2-RPo. Please comment.

By \'nucleation of strand opening\', we mean initial melting of the -10 element (as detected by the RNAP beacon assay used in Feklistov et al., 2017). This paper showed that reagents that close the clamp (i.e. switch region antibiotics such as myxopyronin or T7 Gp2) significantly increase the rate of transcription bubble nucleation. We propose here that restricting the range of clamp opening by TraR could also have this effect (facilitate the very initial steps of -10 element melting). We have tried to clarify this statement (subsection "Conclusion").

The reviewer is correct that Feklistov et al., 2017, also suggested that later steps of RPo formation would require clamp opening, so TraR restriction of clamp opening would be expected to hinder later steps, but this would not be inconsistent with our model -- it would depend on the importance of the later steps to the overall kinetics of RPo formation. Note also that potential hindrance by TraR of later steps due to restrictions in clamp opening would be layered on top of the activation of later steps due to TraR\'s effect on facilitating σ^70^~1.1~ release (Figure 4D).

Also please note that modulation of clamp conformations is only a small part of the multipartite TraR mechanism (Figure 8).

> 5\) There is not a clear synthesis of the variety of inferred structural effects on initiation. How are the effects on the clamp, the bridge helix, and the SLIs integrated to produce activation or inhibition? A kinetic model/schematic that concretely summarizes the kinetic and structural hypotheses for the reader in the context of transitions between different intermediate structures would go a long way to clarifying and synthesizing the proposed TraR model.

We have added such a figure (Figure 8) by adapting the web-based flux calculator (Galburt, 2018) to a four-step linear mechanism for transcription initiation. The figure shows hypothetical energy landscapes for an inhibited and an activated promoter. The figure illustrates proposed effects of TraR binding on specific features of the energy landscapes and shows how TraR can inhibit some promoters but activate others.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

> Essential revisions:
>
> 1\) It would seem from the response that the authors are preparing a subsequent manuscript that will directly address the issue of the mechanism bound to initiation complexes, and that this may be considerably more complicated than the effects of TraR on the polymerase alone. Given that the paper pertains to the mechanism of TraR-based regulation, it is important to delineate how the present work, in particular the molecular mechanisms in the Discussion, stands on its own in absence of the DNA-bound models. In particular, to what extent will the observations described here be relevant after the second paper comes out?

The current paper focuses on the structural mechanisms for both inhibition and activation by TraR. The second paper uses TraR as a tool to populate promoter melting intermediates with an inhibited promoter. The subject of this second paper is not TraR, nor its mechanism. The second paper describes the structures of these intermediates and also presents structure-based biochemical tests to support our proposal that these intermediates describe the normal promoter melting pathway even in the absence of TraR. Thus, the subject of the second paper is promoter melting, not TraR mechanism. There are no results in the second paper that contradict or supersede the results of this *eLife* submission.

> 2\) The response states that the mechanism of inhibition is due to the trapping of an early bound intermediate on repressed promoters. It is also mentioned that on these promoters, bound complexes are short lived and that TraR will likely be present for the entirety of the time. This seems sensible. However, it is also claimed that \"Due to differences in the rate-determining steps at inhibited vs. activated promoters, again described in the Discussion, TraR facilitates rather than inhibits RPo formation at activated promoters. The longer lifetime of the open complex at these promoters results in dissociation of TraR before RNAP dissociates from the promoter, allowing NTP entry and catalysis to proceed.\" In addition, the response states that \"In brief, on activated promoters with long RPo lifetime, TraR would be expected to dissociate from the promoter complex before RNAP would dissociate from the promoter, leaving ample time for activation to occur.\"
>
> The proposed logic for activation is unclear. How can TraR activate transcription via early dissociation? What is \"ample time for activation to occur?\" After it leaves, one might expect that transcription would be de-repressed to basal levels -- not activated. Also, relative to the landscapes shown in Figure 8: these are showing landscapes in the presence and absence of a factor, and factor dissociation during the process is not modeled. It is unclear how the landscapes relate to the hypothesis for activation. Please clarify these points in the manuscript.

We have further revised the Discussion section on "Structural mechanism for TraR-mediated activation" to clarify the model and address the questions raised by the reviewer. The first question concerned how dissociation of TraR from the open complex (RPo) could activate transcription. Confusion about this subject could have arisen because we previously addressed it at the end of the Discussion section on "Structural Mechanism of TraR-mediated inhibition" instead of in the section on "Structural mechanism of activation". We have now moved the explanation to the activation section so that all features of the proposed model for activation are now presented together in one section.

In summary, we have previously published data showing that TraR and its homolog DksA enhance the transcription output from activated promoters relative to that with RNAP alone (Paul et al., 2005; Gopalkrishnan et al., 2017), and that RPo at activated promoters is very stable to competitor challenge (Barker et al., 2001). In addition, kinetic analyses showed that the presence of DksA enhanced the rate of formation and the amount of competitor stable RPo formed at an activated promoter relative to that formed with RNAP alone (Paul et al., 2005). In the present paper we present structural and biochemical evidence that these effects occur primarily because TraR-induces conformational changes in the β subunit that allosterically alter the position of σ~1.1~ in the main DNA binding channel (Figures 1, 4; Video 1), thereby increasing the ability of promoter DNA to displace σ~1.1~ from this channel. TraR also alters the position of β'Si3, contributing to activation (Figure 3). Contrary to what is implied in the comment, these enhancements to the overall rate occur while TraR is still present in the complex -- the increase in the rate and amount of RPo formed while TraR was present leads to the increase in transcription once TraR dissociates.

Since the structural data shown here indicate that TraR bound to the complex would sterically block iNTP access to the active site, t-strand positioning and catalysis (Figure 5; see also Molodtsov et al., 2018), TraR must therefore dissociate from the complex in order for transcription to initiate from the activated promoter. The proposal that TraR dissociates from RPo at an activated promoter prior to dissociation of RNAP from the promoter is consistent with previously published data. The lifetimes of RPo at activated promoters (measured in hours; Barker et al., 2001) are much longer than that of the transcription factors on RNAP (GreB, DksA and by extension TraR; measured in seconds; Stumper et al., 2019).

A second part of the reviewer's comments concerns whether TraR "de-represses basal activity" rather than really activates transcription. We refer to "basal" activity as the activity observed with RNAP alone in the absence of TraR. We have shown previously that TraR increases transcription 4-6 fold over the amount observed without TraR, i.e. it really activates (Gopalkrishnan et al., 2017; also see Figures 3E, 3G, Figure 3---figure supplement 1B, C, E, G, Figure 4C, D). We have revised a paragraph (subsection "A TraR-induced \~18° rotation of βlobe-Si1 plays a major role in transcription regulation", fourth paragraph; re Figure 4D) to clarify what is meant by basal transcription.

We have also included a description in the revised Discussion section about how the energy landscape shows the activation step. We have also modified the kinetic scheme at the top of Figure 8 to reflect TraR (T) dissociation that is required for initiation of RNA chain synthesis and transition of RPo to RPitc.

> 3\) The description of the mechanism via the use of energy landscapes has the potential to greatly clarify the hypotheses made and is a strong addition to the paper. The kinetic/thermodynamic features of the activated and repressed promoters are important should be described in the paper. It seems that one critical component may be the rate of escape. In addition, please provide details on how the flux calculator from Galburt et al. was adapted to a four-state scheme. The on-line calculator appears to only have three states.

The general kinetic/thermodynamic features of inhibited vs. activated promoters are discussed in the Discussion. When the energy diagrams are first introduced (subsection "A TraR-induced \~18° rotation of βlobe-Si1 plays a major role in transcription regulation", last paragraph), we have added a note that the features of inhibited vs. activated promoters are described later in the Discussion. We have also added new references establishing the 3-step minimal linear mechanism for RPo formation (or 4-step mechanism if one includes promoter escape). Basically, complexes at inhibited promoters pass through the pathway rapidly but the final RPo is relatively unstable; in the absence of high NTP concentrations, RPo exists in equilibrium with earlier intermediates. By contrast, activated promoters form RPo slowly, but the RPo that is formed is very stable. In terms of the basic features of the energy diagram, inhibited promoters have low kinetic barriers (low peaks between the valleys) but the valleys going from left to right are generally uphill. Activated promoters have high kinetic barriers (high peaks between the valleys) but the valleys going from left to right are generally downhill. We have tried to capture these basic features in the basal energy diagrams (the black lines) in Figure 4---figure supplement 1C and Figure 8 (these figures have been revised to better illustrate these points).

Regarding the rate of escape, there is no evidence that promoter escape is rate-limiting or that TraR alters the rate of escape from either the activated or inhibited promoters used here. Our models for activation and inhibition propose that TraR would not be associated with the final RPo at the activated promoters (see above response to comment 2), so would not affect the escape rate. For inhibited promoters, TraR depopulates RPo by stabilizing an earlier intermediate complex, thereby preventing initiation. Thus, it is unlikely that TraR remains bound to RPo except in a small fraction of the population in which TraR binding would be expected to sterically occlude catalysis (Figure 5; Molodtsov et al., 2018).

The details of how we used the flux calculator of Galburt, 2018, are now described in Materials and methods (\'Details of flux calculator calculations\'). The input parameters and results of the flux calculator calculations are now tabulated in Supplementary file 2.

> 4\) The promoters shown as examples for activated-and-repressed (Figure 8), or as activated-but-no-effect (Figure 4---figure supplement 1) appear to differ in the rate of promoter escape, which is not mentioned in the manuscript. Could the effect of promoter escape rate revealed by the landscapes be the determinant for TraR-based activation/repression? The landscapes need to be described quantitatively so as to allow others to recapitulate the results. Please comment/clarify.

The details of how we used the flux calculator of Galburt, 2018, are now described in Materials and methods (\'Details of flux calculator calculations\'). The input parameters and results of the flux calculator calculations are now tabulated in Supplementary file 2. The rates of escape for the inhibited promoter in Figure 4---figure supplement 1C and in Figure 8, and the activated promoter in the two cases, are the same, and these are not altered by TraR in our model.

> 5\) There is prior work on the role of different polymerase domains on initiation intermediates (Ruff et al., 2015) that should probably be considered.

We agree with the reviewer that previous work about the role of different RNAP domains should be mentioned. We have included a sentence (subsection "Structural mechanism for TraR-mediated activation", second paragraph) describing conclusions from previous work from the Record and Hinton labs on effects of the deletion of σ~1.1~ on promoter complex formation and stability. Their results, specifically that deletion of σ~1.1~ increases RPo formation at some promoters and decreases it at others, are consistent with effects of the σ~1.1~ deletion on transcription observed here at activated or inhibited promoters (Figure 4; Figure 4---figure supplement 1). Work from the Record lab also showed a role for Si3 in stabilization of RPo (Ruff et al., 2015b). This is consistent with our finding that Si3 plays a role in promoter activation by TraR (Figure 3) and suggests that Si3 could affect activation by altering complex stability. This is now mentioned in our revised Discussion section (see the fourth paragraph of the aforementioned subsection).
